Download curriculum vitae

C.V. for Xianglin Du, Ph.D.
CURRICULUM VITAE
Update: October 6, 2016
NAME:
Xianglin L. Du, MB, MS, PhD
PRESENT POSITION
& ADDRESS:
Professor of Epidemiology
Department of Epidemiology, Human Genetics, and Environmental Sciences
School of Public Health
The University of Texas Health Science Center at Houston (UTHealth)
1200 Pressler Street, RAS-E631
Houston, Texas 77030, USA.
Tel: (713) 500 9956; Fax: (713) 500 9264
E-mail: [email protected]
EDUCATION:
Sep. 1979 – June 1984
MB (Bachelor of Medicine) in Medicine
Medical School/School of Public Health
Anhui Medical University, China.
Sep. 1984 – June 1987
MS (Master of Science) in Clinical Epidemiology
School of Health Services Management
Anhui Medical University, China.
July 1990 – June 1991
World Health Organization Fellow
School of Medicine and Health Sciences
University of Newcastle-upon-Tyne, England, UK.
May 1993 – June 1993
Visiting Research Fellow, Division on Aging
Harvard University Medical School
Boston, Massachusetts, USA.
July 1993 – Jan. 1997
Ph.D. in Epidemiology and Public Health
School of Epidemiology and Health Sciences
University of Manchester Medical School, England, UK.
EMPLOYMENT AND POSITIONS HELD:
Sep. 2012 – present: Professor (with Tenure), Department of Epidemiology, Human Genetics, and Environmental
Sciences, School of Public Health, University of Texas Health Science Center (UTHealth), Houston, Texas, USA.
Jan. 2004 – Aug. 2012: Associate Professor (on Tenure-Track in 2004-2009 and with Award of Tenure effective
from September 1, 2009), Division of Epidemiology, Human Genetics & Environmental Sciences (primary appointment),
with membership in the Center for Health Services Research (since March 2004), adjunct Faculty in the UT-Graduate
School of Biomedical Sciences (since September 2007), and secondary Faculty appointment in the Division of
Management, Policy and Community Health (since June 2008), School of Public Health, University of Texas Health
Science Center, Houston, Texas, USA.
Sep. 2000 – Dec. 2003: Assistant Professor (on Tenure-Track), Department of Internal Medicine, with adjunct
faculty appointment in the Department of Preventive Medicine and Community Health, Associate Member of the
Page 1 of 39
C.V. for Xianglin Du, Ph.D.
Graduate School of Biomedical Sciences, and Fellow of the Sealy Center on Aging, University of Texas Medical Branch,
Galveston, Texas, USA.
Jul. 1999 – Aug. 2000: Assistant Professor (on Non Tenure-Track), Department of Internal Medicine, University
of Texas Medical Branch, Galveston, Texas, USA.
Feb. 1997 – Jun. 1999: Postdoctoral Fellow and Epidemiologist, Sealy Center on Aging, University of Texas
Medical Branch, Galveston, Texas, USA.
July 1993 – Jan. 1997: Research Fellow and Ph.D. candidate, East Lancashire stroke prevention project, School
of Epidemiology & Health Sciences, University of Manchester Medical School, England.
July 1993 – June 1995: Clinical Research Fellow, Manchester Center, International Case-Control Study of Lowdose Oral Contraceptives & Women Health, Univ. of Manchester Medical School, England.
May – June 1993: Visiting Research Fellow, Division on Aging, Harvard University Medical School, Boston,
Massachusetts, USA.
July 1990 – Apr. 1993: World Health Organization Fellow and Research fellow, The Assessment of Outcomes of
Health Care in the Elderly, Departments of Medicine (Geriatrics), and Public Health and Epidemiology, University of
Newcastle upon Tyne, England.
July 1987 – June 1990: Instructor, Department of Social Medicine and Clinical Epidemiology, Anhui Medical
University, China.
Sep. 1984 – June 1987: Graduate Research Assistant, Department of Social Medicine and Clinical Epidemiology,
Anhui Medical University, China.
HONORS AND AWARDS:
Research Awards:
1990 World Health Organization Fellowship Award (1990-91).
1996 International Epidemiology Association Travel Scholarship Award.
2000 First prize award, poster presentations, Annual Health Services and Outcomes Research
Conference, Houston, Texas, USA, November 3, 2000.
2004 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2005 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2006 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2006 Best abstracts award (selected from over 1,600), paper entitled “Racial Disparities and
Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage
Prostate Cancer” at the AcademyHealth Annual Research Meeting, June 2006, Seattle, WA.
2007 Excellence in Research Award, Univ. of Texas School of Public Health, Houston, Texas, USA.
2008 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2009 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2010 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2011 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2012 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2013 Excellence in Research Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2014 Excellence in Research Incentive Award, UTHealth-School of Public Health, Houston, Texas, USA.
2015 Excellence in Research Incentive Award, UTHealth-School of Public Health, Houston, Texas, USA.
Page 2 of 39
C.V. for Xianglin Du, Ph.D.
Teaching Awards:
2008 John P. McGovern Outstanding Teacher for 2008, ‘Teacher of the Year’, selected by the students of the
University of Texas (UT) School of Public Health, Houston, Texas, USA.
2009 Dean’s Teaching Excellence Award, UT-School of Public Health, Houston, Texas, USA.
2010 Dean’s Teaching Excellence Award, UT-School of Public Health, Houston, Texas, USA.
2012 Academic (Teaching and Service) Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2013 Academic (Teaching and Service) Incentive Award, UT-School of Public Health, Houston, Texas, USA.
2014 Academic (Teaching and Service) Incentive Award, UTHealth-School of Public Health, Texas, USA.
2015 Academic (Teaching and Service) Incentive Award, UTHealth-School of Public Health, Texas, USA.
PROFESSIONAL SERVICES:
I. Membership in Professional Societies:
Member of the British Society for Social Medicine (1996-2001)
Member of the American Association for Health Services Research (1998)
Member of the American Society for Epidemiologic Research (1998-2004)
Member of the Gerontological Society of America (1999-2003)
Member of the Academy for Health Services Research (2005-2008)
Member of American Heart Association and American Stroke Association (2008-2009)
II. Reviewer for the Peer-Reviewed Professional Journals (Regular, Periodic or Occasional Review):
Name of the Peer-Reviewed Journals
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
Year of Service
Journal of Epidemiology & Community Health
American Journal of Managed Care
Journal of Aging and Health
Journal of Health Care for the Poor and Underserved
Medical Care
Cancer
Bio-Med Central Cancer
Annals of Epidemiology
Journal of Clinical Epidemiology
Journal of Clinical Oncology
Drugs & Aging
Public Library of Science
American Journal of Public Health
Journal of the National Cancer Institute
International Journal of Gynecological Cancer
Women’s Health Issues
Joint Commission Journal on Quality & Patient Safety
International Journal of Radiation Oncology, Biology, Physics
The Open Health Services & Policy Journal
Cancer Epidemiology, Biomarkers & Prevention
Social Science & Medicine
Journal of Health & Place
Journal of Surgical Oncology
Acta Oncologica
Clinical Medicine: Oncology
American Journal of Epidemiology
Radiation Oncology
Page 3 of 39
1996 - present
1997 - present
1997 - present
1997 - present
1999 - present
1999 - present
1999 - present
2000 - present
2000 - present
2000 - present
2001 - present
2001 - present
2004 - present
2005 - present
2006 - present
2006 - present
2007 - present
2007 - present
2007 - present
2007 - present
2008 - present
2008 - present
2008 - present
2008 - present
2008 - present
2009 - present
2009 - present
C.V. for Xianglin Du, Ph.D.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
Acta Obstetricia et Gynecologica Scandinavica
International Journal of Health Geographics
The Open Pharmocoeconomics & Health Economics Journal
JAMA Internal Medicine (formerly Archives of Internal Medicine)
Pharmacy and Therapeutics
Clinical Medicine Reviews in Oncology
Therapeutics and Clinical Risk Management
Journal of the American Geriatrics Society
BMC Public Health
European Journal of Clinical & Medical Oncology
Value in Health
British Journal of Cancer
Journal of Immigrant and Minority Health
Journal of General Internal Medicine
American Journal of Men's Health
Breast Cancer Research and Treatment
Leukemia and Lymphoma
American Journal of Pharmacy Benefits
International Journal of Surgical Oncology
Archives of Gerontology and Geriatrics
Journal of Infection and Public Health
Clinical Cancer Research
Texas Public Health Journal
Annals of Internal Medicine
International Journal of Women's Health
Journal of Gerontology & Geriatric Research
Journal of Clinical Gastroenterology
Clinical and Experimental Medicine
PLOS ONE
Cancer Causes and Control
Gynecologic Oncology
Heart
Cancer Epidemiology
Expert Opinion on Drug Safety
International Journal of Oncology
Expert Review of Pharmacoeconomics & Outcomes Research
Pharmacoepidemiology and Drug Safety
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Mayo Clinic Proceedings
International Journal of Cancer
2009 - present
2009 - present
2009 - present
2009 - present
2009 - present
2010 - present
2010 - present
2010 - present
2010 - present
2010 - present
2010 - present
2011 - present
2011 - present
2011 - present
2011 - present
2012 - present
2012 - present
2012 - present
2012 - present
2012 - present
2013 - present
2013 - present
2013 - present
2013 - present
2013 - present
2014 - present
2014 - present
2014 - present
2014 - present
2014 - present
2014 - present
2015 - present
2015 - present
2015 - present
2015 - present
2015 - present
2015 - present
2015 - present
2015 - present
2016 - present
Title of the Textbooks Reviewed by Invitation
Year of Service
68.
“Epidemiology: An Introduction for Public Health Practitioners”
proposal for Delmar-Cengage Learning, Health Care Publishing
Sep.-Oct. 2009
69.
“Epidemiologic Research Methods in Public Health Practice”
textbook for Jones and Bartlett Publishers
Nov.-Dec. 2011
III. Services and Committees outside the Institution and for Federal Agencies:
Name of the Committee/Service
Role
Page 4 of 39
Date of Service
C.V. for Xianglin Du, Ph.D.
1.
Clinical Medicine Section of the Gerontological Society of America
Annual Scientific Meeting
Reviewer of the
Abstracts
2001-2003
2.
Cancer Poster Session of the Gerontological Society of America 54th
Annual Scientific Meeting in Chicago, November 2001
Chair of the
Session
2001
3.
Gerontological Society of America 54th Annual Scientific Meeting in
Chicago, November 2001 - Three sessions (End-of-Life, Pain, and
Physical Function).
Chair of the 3
sessions
2001
4.
American Public Health Association (APHA) Annual
Scientific Meeting
Reviewer of the
Abstracts
2005, 2007, 2008
5.
Research Advisory Panel, VA Parkinson’s Disease Research,
Education and Clinical Center (PADRECC) at Houston, VA Medical
Center and Baylor College of Medicine, Houston, TX
Member of the
Advisory Panel
March 2006 December 2008
6.
Member of Advisory Committee to the Texas Cancer Registry (TCR)
and Member of Texas Cancer Data Work Group (TCDWG), TCR,
Texas Department of State Health Services
Member
July 2007 –
May 2016
7.
Peer-reviewed Journal: The Open Health Services & Policy Journal
Member of
Editorial Board
November 2007 November 2010
8.
CDC (Centers for Disease Control and Prevention) Review Panel
Reviewer
April-May 2008
9.
CDC (Centers for Disease Control and Prevention) Review Panel
Reviewer
April-May 2009
10.
Comparative Effectiveness Research on Cancer, American
Association for Cancer Research Annual Conference on Cancer
Prevention Research, December 6-9, 2009, Houston, Texas.
Chairperson of the
Special Session on
CER
December 2009
11.
Agency for Healthcare Research and Quality (AHRQ) Special
Emphasis Panel (iADAPT; RFA-HS-10-004 (R18))
Reviewer
March-April 2010
12.
AHRQ Healthcare Technology and Decision Sciences (HTDS) Study
Section
Reviewer
May-June 2010
13.
Agency for Healthcare Research and Quality (AHRQ) Special
Emphasis Panel (RFA-HS-10-020 (R01))
Reviewer
May-June 2010
14.
Peer-reviewed Journal: BMC Public Health
Editorial Board
Associate Editor
August 2010 April 2013
15.
Research Grants Council Hong Kong, China
Reviewer
March-April 2011
16.
Peer-reviewed Journal: Epidemiology – Open Access
Editorial Board
Associate Editor
June 2011May 2015
17.
Foundation for Polish Science, Poland
Reviewer
April-May 2012
Page 5 of 39
C.V. for Xianglin Du, Ph.D.
18.
PCORI (Patient Centered Outcomes Research Institute) Phase-2 Grant
Review Panel
Scientific
Reviewer
OctoberNovember 2012
19.
NIH Health Delivery and Methodologies Special Emphasis Panel
(SEP)
Reviewer
January-March
2014
20.
2014-2015 Komen Graduate Training in Disparities (GTDR) Grant
Full Applications
Scientific
Reviewer
January-February
2015
21.
NIH Special Emphasis Panel (SEP)
Reviewer
May-June 2015
22.
Cancer Research UK (United Kingdom)
Reviewer
July-August 2016
IV. Institutional and Community Services:
Name of the Committee/Service
Role
Term/Date of Service
1.
Rehabilitation Science Core Faculty Committee,
University of Texas Medical Branch at Galveston
Member
March 2002 - Dec. 2003
2.
Admission Triage Committee, Division of Epidemiology, University of
Texas School of Public Health at Houston
Member
July 2004 - August 2008
3.
Curriculum Committee, Division of Epidemiology (now Department of
Epidemiology, Human Genetics, and Environmental Sciences),
University of Texas School of Public Health at Houston
Member
Dec. 2004-present
4.
Faculty Search Committee for Health Services and Outcomes, Division
of Management, Policy and Community Health, SPH
Member
2005
5.
Search Committee for Administrative Service Officer (ASO-III),
Division of Epidemiology, UT-SPH
Member
August-October 2006
6.
Sub-Committee on Teaching Assistant (TA) Allocation for
Epidemiology Courses, Division of Epidemiology, UT-SPH
Member
July-August 2006
7.
Advisory Committee of the UT-SPH Cancer Prevention &
Control Training & Career Development Program, Division of
Behavioral Science and Health Promotion, UT-SPH
Member
April 2007 - present
8.
IRB (Institutional Review Board) Committee (Committee for the
Protection of Human Subjects) of the University of Texas Health
Science Center in Houston
Member
Sep. 2007 - Aug. 2016
9.
Faculty Development Leave Committee,
University of Texas School of Public Health at Houston
Member
September 2007 - Aug.
2009
10.
Peer Review Panel of the UTSPH for the PRIME (Pilot Research
Investigations with Mentoring for Excellence) and Bridging and NearMiss Grant Funds, UT-SPH at Houston
Member
September 2007 August 2009
(two-year term)
11.
Search Committee for Four Epidemiology Faculty Positions, UTSPH
Member
May 2008 - June 2010
Page 6 of 39
C.V. for Xianglin Du, Ph.D.
12.
AAR Peer Reviewer for the UT-SPH
Member
Dec. 2008 - Jan. 2009
13.
Search Committee for the Director of the Health Outcomes Research,
UTSPH
Member
May 2009 - June 2010
14.
Faculty Search Committee – Comparative Effectiveness /Outcomes
Research (10 Positions), UTSPH
Member
Nov. 2010 - Aug. 2011
15.
‘Cancer Epidemiology Concentration’ Program Working Group,
UTSPH
Member
Oct. 2011 - July 2012
16.
Epidemiology Preliminary Exam Committee
Member
Aug. 2012 - July 2014
17.
UT-SPH School-wide Tenure and Promotion (T&P) Committee
Co-Chair
April 2013 - Jan. 2014
18.
UT-SPH School-wide Tenure and Promotion (T&P) Committee
Chair
Feb. 2014 - Feb. 2015
19.
Faculty Search Committee at UT-SPH Brownsville Regional Campus –
Epi+Behavioral Sci joint Faculty with focus on CER, UTSPH
Member
July 2015 - March 2016
20.
Search Committee for UT-SPH Dallas Regional Dean, UTSPH
Member
January - Sep. 2016
21.
Epidemiology Preliminary Exam Committee
Member
Aug. 2016 - present
TEACHING ACTIVITIES:
Part-A: Teaching Responsibilities at UTMB in Galveston (in 1999-2003):
I. Class Teaching at UTMB (University of Texas Medical Branch at Galveston):
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 1999 at UTMB.
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 2001 at UTMB.
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 2002 at UTMB.
Co-Instructor, the course module PMCH6330 “Introduction to Epidemiology”, 2003 at UTMB.
Guest Lecturer, the course module PMCH6330 “Introduction to Epidemiology”, 2004 at UTMB.
Lead Instructor: Module PMCH6215 “Epidemiologic Research Using Large Public Databases”,
Spring Semester 2002 (a new course created and taught) at UTMB.
Lead Instructor: Module PMCH6215 “Epidemiologic Research Using Large Public Databases”,
Fall Semester, 2003 at UTMB.
II. Mentoring and Committee Advising:
Mentor, for a second year clinical geriatric fellow, 1999.
Mentor, for a first year medical student on the Summer Medical Research Project, 2000.
Mentor, for a postdoctoral fellow (Max E. Otiniano, MD, MPH) on the minority aging
projects, March 2001 – August 2002.
Mentor, for a geriatric and oncology fellow (Cynthia Osborne, MD) on the breast cancer
research, August 2001 – July 2002.
Mentor, for a clinical oncologist (Dennie V. Jones, MD) working on the NIH minority
supplement grant, March 2002 – December 2003.
Part-B: Teaching Responsibilities at UTHealth in Houston (from January 2004 to present):
Page 7 of 39
C.V. for Xianglin Du, Ph.D.
I. Class Teaching at UT-SPH (University of Texas School of Public Health):
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
Course Number and Name
Role (% effort)
Semester/
Year
Number of
students
PH2711-Advanced Epidemiologic Methods II
(guest lecture on the Cox survival analysis)
PH2998-Epidemiologic Research Using ClaimsBased Healthcare Data
PH2710-Advanced Epidemiologic Methods I
PH2610-Introduction to Epidemiology
PMCH6215-Introduction to Epidemiology, UTMB
PH2710-Advanced Epidemiologic Methods I
PH2711-Advanced Epidemiologic Methods II
(lecture on the Cox survival project)
PH2998-Epidemiologic Study Using Claims-Based
Healthcare Data
PH2710-Advanced Epidemiologic Methods I
PH2710-Advanced Epidemiologic Methods I
PH2610-Introduction to Epidemiology
PH2710-Advanced Epidemiologic Methods I
PH2610(ITV)-Introduction to Epidemiology
PH2612-Introduction to Epidemiology for Majors
PH2710-Advanced Epidemiologic Methods I
PH2612-Introduction to Epidemiology for Majors
PH2612-Introduction to Epidemiology for Majors
PH2612-Epidemiology I (ITV to all campuses)
PH2612-Epidemiology I
PH2612-Epidemiology I (ITV to all campuses)
PH2612-Epidemiology I
PH2612-Epidemiology I (ITV to all campuses)
PH2612-Epidemiology I
PHM2612-Epidemiology I
PHM2612-Epidemiology I
PHD2711-Epidemiology IV (ITV to all campuses)
PHM2612-Epidemiology I
PHD2990- Epidemiology Seminar (ITV to all
campuses)
PHM2612-Epidemiology I
PHD2990- Epidemiology Seminar (ITV to all
campuses)
PHM2612-Epidemiology I
PHD2990- Epidemiology Seminar (ITV to all
campuses)
Guest Lecturer
Spring 2004
19
Lead Instructor (100%)
Fall 2004
10
Co-Instructor (10%)
Guest Lecturer
Guest Lecturer
Co-Instructor (10%)
Guest Lecturer
Fall 2004
Fall 2004
Fall 2004
Spring 2005
Spring 2005
44
85
25
18
20
Lead Instructor (100%)
Fall 2005
10
Guest Lecturer
Co-Instructor (5%)
Lead Instructor (100%)
Co-Instructor (5%)
Lead Instructor (100%)
Lead Instructor (100%)
Co-Instructor (5%)
Lead Instructor (100%)
Guest Lecturer
Lead Instructor (100%)
Guest Lecturer
Lead Instructor (100%)
Guest Lecturer
Lead Instructor (100%)
Guest Lecturer
Lead Instructor (100%)
Lead Instructor (100%)
Guest Lecturer
Lead Instructor (100%)
Lead Instructor (50%)
Fall 2005
Spring 2006
Summer 2006
Spring 2007
Summer 2007
Fall 2007
Spring 2008
Fall 2008
Spring 2009
Fall 2009
Spring 2010
Fall 2010
Spring 2011
Fall 2011
Spring 2012
Fall 2012
Fall 2013
Spring 2014
Fall 2014
Fall 2014
20
24
8
32
12
41
42
34
26
31
18
56
20
54
17
19
18
12
35
14
Lead Instructor (100%)
Lead Instructor (50%)
Fall 2015
Fall 2015
34
14
Lead Instructor (100%)
Lead Instructor (50%)
Fall 2016
Fall 2016
24
12
II. Individual Study (PH2999), Practicum (PH9997), Thesis (PH9998)/Dissertation (PH9999) Research:
1.
Name of Students
Degree Program
(major field)
Type of Teaching
Yan Xing
PhD (health service)
Individual Study
Page 8 of 39
Credit
Hours
3
Semester/Year
Summer 2004
C.V. for Xianglin Du, Ph.D.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
Shenying Fang
Liqian Liu
Nidhi Rohatgi
Matthew Shim
Nidhi Rohatgi
Evette Toney
Dale Hardy
Laurens Holmes
Evette Toney
Amit Habbu
Nidhi Rohatgi
Laurens Holmes
Laurens Holmes
Shenying Fang
Ravi Chopra
Michelle Lacour
David Yang
Michelle Lacour
Emily Bettis
Michelle Lacour
Yi Min
Stephen Gruschkus
David Yang
Jessica Sun
Sachin Kamble
Michelle Lacour
Sachin Kamble
Chung-Yuan Hu
Arica White
Ravi Chopra
Michelle Lacour
Kavita Sail
Chung-Yuan Hu
Rui Xia
Arica White
Robin Lacour
Emily Bettis
Sachin Kamble
David Yang
Ravi Chopper
Chung-Yuan Hu
Brian Badgwell
Joyce Li
Brady Moffett
Nadia Barahmani
Brian Badgwell
Joyce Li
Sachin Kamble
Arica White
Monawar Hosain
Judith Wendt
Beatrix Foldi
Joyce Li
Chung-Yuan Hu
Rita Sheth
Nadia Barahmani
PhD (biostatistics)
MS (epidemiology)
MS (epidemiology)
PhD (epidemiology)
MS (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
DrPH (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
MS (epidemiology)
DrPH (epidemiology)
DrPH (epidemiology)
PhD (biostatistics)
MS (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
PhD (biostatistics)
PhD (health service)
MPH (epidemiology)
PhD (biostatistics)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MS (epidemiology)
MPH (epidemiology)
PhD (health service)
PhD (epidemiology)
PhD (biostatistics)
PhD (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MS (epidemiology)
PhD (epidemiology)
MS (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MS (epidemiology)
MS (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
MS (epidemiology)
Practicum
Individual Study
Individual Study
Individual Study
Thesis Research
Individual Study
Individual Study
Individual Study
Individual Study
Thesis Research
Thesis Research
Dissertation Research
Dissertation Research
Practicum
Practicum
Thesis Research
Practicum
Practicum
Practicum
Thesis Research
Individual Study
Individual Study
Individual Study
Individual Study
Practicum
Thesis Research
Thesis Research
Practicum
Individual Study
Thesis Research
Thesis Research
Individual Study
Individual Study
Individual Study
Individual Study
Thesis Research
Thesis Research
Thesis Research
Thesis Research
Thesis Research
Practicum
Individual Study
Practicum
Practicum
Thesis Research
Thesis Research
Thesis Research
Thesis Research
Dissertation Research
Dissertation Research
Individual Study
Individual Study
Individual Study
Practicum
Practicum
Thesis Research
Page 9 of 39
3
1
3
4
2
1
2
1
5
3
3
1
1
4
3
3
3
3
3
3
2
2
1
2
3
3
3
1
3
3
5
3
3
3
1
9
3
3
3
3
1
1
3
3
5
2
3
3
3
3
3
3
3
2
3
3
Fall 2004
Summer 2005
Summer 2005
Summer 2005
Fall 2005
Fall 2005
Fall 2005
Spring 2006
Spring 2006
Spring 2006
Spring 2006
Spring 2006
Summer 2006
Fall 2006
Fall 2006
Fall 2006
Spring 2007
Spring 2007
Spring 2007
Spring 2007
Summer 2007
Summer 2007
Summer 2007
Summer 2007
Summer 2007
Summer 2007
Fall 2007
Fall 2007
Fall 2007
Fall 2007
Fall 2007
Spring 2008
Spring 2008
Spring 2008
Spring 2008
Spring 2008
Spring 2008
Spring 2008
Spring 2008
Spring 2008
Spring 2008
Summer 2008
Summer 2008
Summer 2008
Summer 2008
Summer 2008
Summer 2008
Summer 2008
Summer 2008
Summer 2008
Fall 2008
Fall 2008
Fall 2008
Fall 2008
Fall 2008
Fall 2008
C.V. for Xianglin Du, Ph.D.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
Emily Bettis
Chung-Yuan Hu
Arica White
Stephen Gruschkus
Joyce Li
Chung-Yuan Hu
David Yang
Sachin Kamble
Rita Sheth
Brady Moffett
Chung-Yuan Hu
Arica White
Stephen Gruschkus
Beatrix Foldi
Brady Moffett
Arica White
Stephen Gruschkus
Michelle Ludwig
Brady Moffett
Jessica Clague
Peter Abotchie
Chung-Yuan Hu
Michelle Ludwig
Brady Moffett
Jessica Clague
Peter Abotchie
Chung-Yuan Hu
Michelle Ludwig
Chung-Yuan Hu
Michelle Ludwig
Chung-Yuan Hu
Zhannat Nurgalieva
Michelle Ludwig
Zhannat Nurgalieva
Kathryn Kimbrough
Zhannat Nurgalieva
Li Nan
Laitan O. Lansebe
Adeniran A. Olaoya
Zhannat Nurgalieva
Michelle Ludwig
Li Nan
Zhannat Nurgalieva
Saurav Suman
Michelle Ludwig
Zhannat Nurgalieva
Saurav Suman
Michelle Ludwig
Zhannat Nurgalieva
Tong, Liyue
Michelle Ludwig
Tong, Liyue
Michelle Ludwig
Jose Zevallos
Poonawalla, Insiya
Tong, Liyue
MPH (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
Thesis Research
Dissertation Research
Dissertation Research
Dissertation Research
Individual Study
Practicum
Thesis Research
Thesis Research
Thesis Research
Thesis Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Thesis Research
Dissertation Research
Dissertation Research
Individual Study
Thesis Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Thesis Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Cancer Epi Using Medicare
Cancer Disparity Research
Dissertation Research
Dissertation Research
MPH in Epidemiology
Practicum
PhD (epidemiology)
Dissertation Research
Thesis Research
DrPH (HPBS)
PhD (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
DrPH (HPBS)
MS in Epidemiology
MPH in Epidemiology
MPH in Epidemiology
Practicum
Practicum
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
Dissertation Research
Dissertation Research
Thesis Research
Dissertation Research
MPH in Epidemiology
Practicum
PhD (epidemiology)
PhD (epidemiology)
Dissertation Research
Dissertation Research
Thesis Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Individual Study
Dissertation Research
Dissertation Research
MS in Epidemiology
MPH in Epidemiology
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
Page 10 of 39
3
3
3
3
3
1
3
3
3
3
3
3
3
4
3
3
3
4
3
5
3
3
5
3
5
4
3
3
1
3
2
3
3
3
3
1
3
3
3
2
3
1
2
3
3
2
3
3
1
1
3
3
3
3
3
3
Fall 2008
Fall 2008
Fall 2008
Fall 2008
Spring 2009
Spring 2009
Spring 2009
Spring 2009
Spring 2009
Spring 2009
Spring 2009
Spring 2009
Spring 2009
Spring 2009
Summer 2009
Summer 2009
Summer 2009
Fall 2009
Fall 2009
Fall 2009
Fall 2009
Fall 2009
Fall 2009
Spring 2010
Spring 2010
Spring 2010
Spring 2010
Spring 2010
Summer 2010
Summer 2010
Summer 2010
Summer 2010
Fall 2010
Spring 2011
Summer 2011
Summer 2011
Fall 2011
Fall 2011
Fall 2011
Fall 2011
Fall 2011
Spring 2012
Spring 2012
Spring 2012
Summer 2012
Summer 2012
Summer 2012
Fall 2012
Fall 2012
Fall 2012
Spring 2013
Spring 2013
Summer 2013
Summer 2013
Fall 2013
Fall 2013
C.V. for Xianglin Du, Ph.D.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
Michelle Ludwig
Mohammad Shakhatreh
John Teke
Poonawalla, Insiya
Mohammad Shakhatreh
Tong, Liyue
Wang, Xin
Poonawalla, Insiya
Chi Nguyen
Chen Ying
Xerxes Nozer Pundole
Poonawalla, Insiya
Chi Nguyen
Chen Ying
Joshua Swan
Xerxes N. Pundole
Chi Nguyen
Chen Ying
Shuangshuang Fu
Xerxes N. Pundole
Xiaotao Zhang
Chi Nguyen
Kathy M. Abusager
Aylin Tansel
Joshua Swan
Aylin Tansel
Xerxes N. Pundole
Chen Ying
Chi Nguyen
Xerxes N. Pundole
Chen Ying
Catherine Hambleton
Aylin Tansel
Shuangshuang Fu
Christine N. Spencer
Xerxes N. Pundole
Chen Ying
Aylin Tansel
Chi Nguyen
PhD (epidemiology)
MPH in Epidemiology
MS (Biostatistics)
PhD (epidemiology)
MPH in Epidemiology
PhD (epidemiology)
PhD (pharmacy) at Univ. of Houston
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH in Epidemiology
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH in Epidemiology
MPH in Epidemiology
MPH in Epidemiology
MPH in Epidemiology
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
PhD (epidemiology)
MPH in Epidemiology
MPH in Epidemiology
PhD (epidemiology
PhD in Epidemiology
PhD (epidemiology)
PhD (epidemiology)
MPH in Epidemiology
PhD (epidemiology)
Dissertation Research
Thesis Research
Thesis Research
Dissertation Research
Thesis Research
Dissertation Research
Individual Study
Dissertation Research
Dissertation Research
Individual Study
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Thesis Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Individual Study
Individual Study
Individual Study
Practicum
Thesis Research
Thesis Research
Individual Study
Dissertation Research
Dissertation Research
Individual Study
Dissertation Research
Dissertation Research
Practicum
Thesis Research
Dissertation Research
Dissertation Research
Dissertation Research
Dissertation Research
Thesis Research
Dissertation Research
3
3
1
3
3
3
3
3
3
3
5
3
3
3
3
4
3
3
3
4
3
2
3
3
3
3
2
3
3
3
3
1
3
2
2
3
3
3
2
Fall 2013
Fall 2013
Spring 2014
Spring 2014
Spring 2014
Spring 2014
Spring 2014
Fall 2014
Fall 2014
Fall 2014
Spring 2015
Spring 2015
Spring 2015
Spring 2015
Summer 2015
Fall 2015
Fall 2015
Fall 2015
Fall 2015
Fall 2015
Fall 2015
Fall 2015
Fall 2015
Spring 2016
Spring 2016
Spring 2016
Spring 2016
Spring 2016
Spring 2016
Summer 2016
Summer 2016
Summer 2016
Summer 2016
Fall 2016
Fall 2016
Fall 2016
Fall 2016
Fall 2016
Fall 2016
III. Member of the Academic/Thesis/Dissertation Committees for Students:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
Name of Students
Degree Program
(type of doctoral committee)
Study Period
Status or Month/Year of
Graduation
Lu Mei
Kelly Merriman
Liu Hui
Liqian Liu
Yan Xing
Shenying Fang
Zhigang Duan
Liz Ye Han
Prashant Gundre
Catherine Gomez
Xuemei Wang
MS in Biostatistics (minor in Epi)
PhD in Epidemiology (dissertation)
MS in Biostatistics (minor in Epi)
MS in Epidemiology (thesis)
PhD in Biostatistics (minor in Epi)
PhD in Biostatistics (minor in Epi)
PhD in Biostatistics (minor in Epi)
MPH in Biostatistics (thesis)
MPH in community health
MPH in health promotion
PhD in Biostatistics (minor in Epi)
Feb. 2004-Dec. 2004
Sep. 2004-Nov.2007
Dec. 2004-Dec. 2005
Aug. 2004-Dec. 2005
Sep. 2004-Aug. 2006
Dec. 2004-Mar. 2006
Jan. 2005-Feb. 2006
Mar. 2004-Mar. 2006
Aug. 2004-Aug. 2005
Aug. 2004-Nov. 2010
Oct. 2004- Aug. 2006
Graduated in 12/2004
Graduated in 11/2007
Graduated in 12/2005
Graduated in 12/2005
Passed qualifying exam
Passed qualifying exam
Passed qualifying exam
Graduated in 03/2006
Moved away/discontinued
Graduated in 11/2010
Passed qualifying exam
Page 11 of 39
C.V. for Xianglin Du, Ph.D.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
Mai Pham
Julie S. Beaver
Kai Sun
Rui Xia
Tuan Vo
Monawar Hosain
Sandra Olfert
Desiree Jones
Mala Pande
Liu Mei
Yu-Feng Lin
Han Liu
Ashwini Mhatre
Javier Berrios-Rivera
Min Yi
Jun Liu
Jun Liu
Kaiyan Jing
Matthew Shim
Abeer B. Alsarraj
Scott Stover
Dawen Sui
Ning Zhang
Rui Xia
Kavita Sail
Sofia De achaval
Saqr Hatem
Caimiao Wei
Caimiao Wei
Ma Long
Liu Mei
Wang Gangduo
Niu Jiangong
Judith Wendt (MS)
Zhang, Xuan
Yi Cai
Bo He
Marc Kowalkowski
Panchal, Janki M
Wang Ying
Aditi Kadakia
Wang, Tao
Duong T. Tran
Lee Cheng
Jinhai Huo
Hong Zhang
Russell, Heidi (MD)
Park, Minjeong
Adhikari, Deepak
Malla, Rashmi
Ling, Kok Yan
Yue Song
Yang Zhao
Marc Kowalkowski
John Teke
Kim, Jung Hyun
MPH in Health Service and Policy
MS in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (dissertation)
PhD in Biostatistics (minor in Epi)
DrPH in Health Services (dissertation)
PhD in Molecular Epi (from GSBS)
MS in Epidemiology (thesis)
MS in Epidemiology
PhD in Biostatistics (minor in Epi)
PhD in Biostatistics (minor in Epi)
PhD in Biostatistics (dissertation)
MS in Biostatistics (minor in Epi)
PhD in Epidemiology (dissertation)
MS in Epidemiology (thesis)
PhD in Health Policy (minor in Epi)
PhD in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
PhD in Biostatistics (minor in Epi)
PhD in Health Services (dissertation)
MS in Epidemiology (thesis)
PhD in Health Policy (minor in Epi)
PhD in Biostatistics (minor in Epi)
PhD in Biostatistics (dissertation)
PhD in Biostatistics (minor in Epi)
PhD in Biostatistics (dissertation)
MS in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
PhD in Epidemiology (dissertation)
PhD in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
PhD in Biostatistics (minor in Epi)
MS in Epidemiology (thesis)
PhD in Health Economics (dissertation)
MS in Biostatistics (minor in Epi)
MS in pharmacy (Univ. of Houston)
PhD in Biostatistics (minor in Epi)
PhD in Epidemiology (dissertation)
PhD in Biostatistics (dissertation)
PhD in Health Services (dissertation)
PhD in Biostatistics (dissertation)
PhD in Health Services (dissertation)
PhD in Biostatistics (dissertation)
MS in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
MS in Biostatistics (minor in Epi)
PhD in Epidemiology (dissertation)
MS in Biostatistics (minor in Epi)
PhD in Health Services (dissertation)
Page 12 of 39
Aug. 2005-Aug. 2006
Oct. 2004-Dec. 2005
Aug. 2005-Aug. 2006
Aug. 2005-Aug. 2007
Jan. 2005-Aug. 2006
Aug. 2005-Aug. 2008
Aug. 2005-Mar. 2006
Aug. 2005-May 2006
Sep. 2006-Nov. 2007
Jun. 2006-Mar. 2008
Oct. 2006-Jul. 2009
Nov. 2006-May 2007
Nov. 2006-Nov. 2008
Jan. 2007-Jan. 2009
Jan. 2007-Feb. 2009
Jan. 2007-Oct. 2009
Jan. 2012-Nov. 2012
Feb. 2007-Mar. 2008
Feb. 2007-Jan. 2008
Feb. 2008-Oct. 2009
Apr. 2007-Apri. 2010
Mar. 2008-Mar. 2011
Mar. 2008-May 2012
Apr. 2008-Mar. 2010
May 2008-Apr. 2010
Oct. 2008-Aug. 2009
Dec. 2008-Jun. 2009
Jan. 2009-Sep. 2010
May 2012-May 2015
Apr. 2009-Apr. 2011
Aug. 2009-May 2010
Aug. 2009-May 2012
Oct. 2009-Oct. 2011
Dec 2009- May 2012
Mar. 2010-Feb. 2011
Apr. 2010-Aug. 2011
Apr. 2010-Oct. 2011
June 2010-Nov. 2010
Oct. 2010-May 2012
Oct. 2010-July 2011
Mar. 2011-Aug. 2011
April 2011-Oct. 2012
Sep. 2011-July 2013
Nov. 2011-Nov. 2012
Jan. 2012-May 2013
Mar. 2012-May 2013
July. 2012- July 2013
Aug. 2012-Dec. 2013
Aug. 2012-July 2013
Sep. 2012- May 2013
Oct. 2012- May 2013
Jan. 2013-May 2013
Jan. 2013-June 2013
Feb. 2013-Aug. 2013
Feb. 2013-Aug. 2014
Aug. 2013-present
Discontinued
Graduated in 12/2005
Graduated in 08/2006
Graduated in 08/2007
Graduated in 08/2006
Graduated in 08/2008
Graduated in 03/2006
Graduated in 05/2006
Graduated in 11/2007
Passed qualifying exam
Graduated in 07/2009
Graduated MS in 05/2007
Graduated in 11/2008
Moved away/discontinued
Passed qualifying exam
Passed qualifying exam
Graduated in 11/2012
Graduated in 03/2008
Graduated in 01/2008
Graduated in 10/2009
Changed the program
Changed the program
Graduated in 05/2012
Passed qualifying exam
Graduated in 04/2010
Graduated in 08/2009
Passed qualifying exam
Passed qualifying exam
Graduated in 05/2015
Passed qualifying exam
Graduated in 05/2010
Graduated in 05/2012
Changed the program
Graduated in 05/2012
Passed qualifying exam
Graduated in 08/2011
Passed qualifying exam
Graduated in 11/2010
Graduated in 05/2012
Graduated in 07/2011
Graduated in 08/2011
Graduated in 10/2012
Graduated in 07/2013
Graduated in 11/2012
Graduated in 05/2013
Graduated in 05/2013
Graduated in 07/2013
Graduated in 12/2013
Graduated in 07/2013
Graduated in 05/2013
Graduated in 05/2013
Graduated in 05/2013
Graduated in 06/2013
Graduated in 08/2013
Graduated in 08/2014
C.V. for Xianglin Du, Ph.D.
66.
67.
68.
69.
70.
71.
72.
73.
Chung, Tong Han
Chuan Hong
Chuo, Ching-Yi
Rohan C. Parikh
Min-Ji Kwak
Maria A. Ukhanova
Chen, Tsun-Hsuan (Joy)
Christine N. Spencer
PhD in Health Services (dissertation)
PhD in Biostatistics (dissertation)
PhD in Epidemiology (dissertation)
PhD in Health Services (dissertation)
DrPH in Health Services (dissertation)
PhD in Health Services (dissertation)
PhD in Environmental Sci (dissertation)
PhD in Epidemiology (dissertation)
Aug. 2013-Aug. 2015
May 2014-May 2016
Aug. 2014-present
Aug. 2014-Aug. 2015
Nov. 2014-present
Feb. 2015-present
Oct. 2015-present
Jun. 2016-present
Graduated in 08/2015
Graduated in 05/2016
Graduated in 08/2015
IV. Advisor and/or Supervisor of Academic/Thesis/Dissertation Committees for Students:
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
Name of Students
(degree before entry)
Degree Program
(type of doctoral committee)
Study Period
Status or Month/Year
of Graduation*
Nidhi Rohatgi (MD)
Laurence Holmes (MD, MPH)
Laurence Holmes (MD, MPH)
Thanh Q. Tran (MS)
Amit Habbu (MBBS)
Evette Toney (MPH)
Judith Wendt (MS)
Michelle Lacour (BS)
Ravi Chopra (MD)
Beatrix Foldi (MD)
Nadia Baramani (MD)
Emily Bettis (BS)
Sachin Kamble (MD)
Christian Gutierrez (MPH)
Sarah Duong (BS)
David Yang (BS)
Chung-Yuan Hu (MPH)
Chung-Yuan Hu (MPH)
Jonas De Souza (MD fellow)
Joyce Li (MD fellow)
Robin A. Lacour (MD fellow)
Larissa Meyer (MD fellow)
Rita Sheth (MD fellow)
Jessica Clague (MS)
Jessica Clague (MS)
Brady Moffett (PharmD)
Brian Badgwell (MD fellow)
Arica White (MPH)
Zhannat Nurgalieva (MD, MPH)
Zhannat Nurgalieva (MD, MPH)
Michelle Ludwig (MD, MPH)
Michelle Ludwig (MD, MPH)
Stephen Gruschkus (MPH)
Daniel A. Anaya (MD)
Peter N. Abotchie (MPH)
Ali Mazloom (MD)
Kathryn A. Kimbrough (MD)
Li Nan (MD)
Laitan O. Lansebe (BS)
Olaoya, Adeniran A (MD)
Suman, Saurav (MD)
Yucel, Emre (BS, MS)
MS in Epidemiology (thesis)
DrPH in Epidemiology (qualifying)
DrPH in Epidemiology(dissertation)
PhD in Epidemiology (qualifying)
MPH in Disease Control
PhD in Epidemiology (qualifying)
PhD in Epidemiology (qualifying)
MPH in Epidemiology (thesis)
MS in Epidemiology
PhD in Epidemiology (qualifying)
MS in Epidemiology (thesis)
MPH in Epidemiology (thesis)
MPH in Epidemiology
PhD in Epidemiology (qualifying)
MPH in Epidemiology
MPH in Epidemiology (thesis)
PhD in Epidemiology (qualifying)
PhD in Epidemiology (dissertation)
MS in Epidemiology
MPH in Epidemiology (thesis)
MPH in Epidemiology (thesis)
MPH in Epidemiology
MPH in Epidemiology (thesis)
PhD in Epidemiology (qualifying)
PhD in Epidemiology (dissertation)
MPH in Epidemiology (thesis)
MS in Epidemiology (thesis)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (qualifying)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (qualifying)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (dissertation)
MPH in Epidemiology
DrPH in HPBS (dissertation)
MPH in Epidemiology
MPH in Epidemiology (capstone)
MS in Epidemiology (thesis)
MPH in Epidemiology (thesis)
MPH in Epidemiology (capstone)
MPH in Epidemiology (capstone)
PhD in Epidemiology (qualifying)
Aug. 2004-May 2006
Aug. 2004-Jan. 2006
Jan. 2006-Aug. 2006
Aug. 2004-Mar. 2007
Jan. 2005-Jun. 2006
Jan. 2005-Feb. 2006
Jan. 2005-May 2009
Aug. 2005-Nov. 2007
Aug. 2005-Jun. 2008
Aug. 2005-Jul. 2008
Aug. 2005-Nov. 2008
Jan. 2006-Nov. 2008
Jan. 2006-Jan. 2010
Jun. 2006-Jun. 2009
Aug. 2006-Jul. 2007
Aug. 2006-Apr. 2009
Aug. 2006-Feb. 2008
Mar. 2008-Aug. 2010
Jan. 2007-Jan. 2009
Jan. 2007-Apr. 2009
Jul. 2007-Mar. 2008
Aug. 2007-Mar. 2008
Aug. 2007-Apr. 2009
Aug. 2007-May 2009
May 2009-Apr. 2010
Jan. 2008-Apr. 2010
Jan. 2008-Aug. 2008
Mar. 2008-Aug. 2009
Aug. 2008-June 2010
June 2010-Nov. 2012
Aug. 2008-Aug. 2009
Aug. 2009-Dec. 2013
Oct. 2008-Aug. 2009
Graduated in 05/2006
Passed qualifying exam
Graduated in 08/2006
Passed qualifying exam
Left for residence training
Passed qualifying exam
Passed qualifying exam
Graduated in 11/2007
Moved away/discontinued
Passed qualifying exam
Graduated in 11/2008
Graduated in 11/2008
Moved away/discontinued
Moved away/discontinued
Transferred for MD/MPH
Graduated in 04/2009
Passed qualifying exam
Graduated in 08/2010
Transferred to U. Chicago
Graduated in 04/2009
Graduated in 03/2008
Changed to genetic epi
Graduated in 04/2009
Passed qualifying exam
Graduated in 04/2010
Graduated in 04/2010
Graduated in 08/2008
Graduated in 08/2009
Passed qualifying exam
Graduated in 11/2012
Passed qualifying exam
Graduated in 12/2013
Graduated in 08/2009
Moved away/discontinued
Graduated in 05/2010
Transferred to another U.
Graduated in 05/2012
Graduated in 05/2012
Graduated in 05/2012
Graduated in 05/2012
Graduated in 05/2014
Changed the program
Page 13 of 39
Jan. 2009-Jan. 2012
Jun. 2009-May 2010
Aug. 2009-Aug. 2010
Aug. 2010-May 2012
Aug. 2010-May 2012
Aug. 2010-May 2012
Oct. 2010-May 2012
Dec. 2010-Jan. 2014
Aug. 2011-Dec. 2011
C.V. for Xianglin Du, Ph.D.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
Luis J. Garcia Morales (MD)
Alaina J. Brown (MD)
Mohammad Shakhatreh (MD)
Tong, Liyue (MS)
Poonawalla, Insiya B (MPH)
Chen Ying (MS)
Chen Ying (MS)
Shuangshuang Fu (MS)
Shuangshuang Fu (MS)
Xerxes Nozer Pundole (MPH)
Xerxes Nozer Pundole (MPH)
Anand, Grace Shebha (MD)
Chi Nguyen (MPH)
Xiaotao Zhang (MD, MS)
Joshua Swan (MS)
Aylin Tansel (MD)
Abhinav Dodeja (MD)
Kathy M. Abusager (BS)
Catherine Hambleton (MD)
Alexia Wilson (BA)
Ikoma, Naruhiko (MD)
Tam, Samantha (MD)
Nair, Mrudula (DDS)
Smith, Robert (BS)
MS in Epidemiology
MPH in Epidemiology (capstone)
MPH in Epidemiology (thesis)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (qualifying)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (qualifying)
PhD in Epidemiology (dissertation)
PhD in Epidemiology (qualifying)
PhD in Epidemiology (dissertation)
MPH in Epidemiology
PhD in Epidemiology (dissertation)
PhD in Epidemiology (qualifying)
MPH in Epidemiology (thesis)
MPH in Epidemiology
MPH in Epidemiology
MPH in Epidemiology (capstone)
MPH in Epidemiology
MPH in Epidemiology
MS in Epidemiology
MPH in Epidemiology
MPH in Epidemiology
MPH in Epidemiology
Jan. 2012-May 2014
Aug. 2012-Jan. 2014
Aug. 2012-May 2014
Oct. 2012-Jan. 2014
Dec. 2012-May 2015
Aug. 2013-Jan. 2014
Feb. 2014-present
Aug. 2013-July 2015
Aug. 2015-present
Aug. 2013-July 2014
Aug. 2014-present
Jan. 2014-present
Jan. 2014-present
Aug. 2014-July 2016
Aug. 2014-May 2016
Aug. 2014-present
Aug. 2014-present
Feb. 2015-Dec. 2015
Aug. 2015-present
Jan. 2016-present
Aug. 2016-present
Aug. 2016-present
Aug. 2016-present
Aug. 2016-present
Changed the program
Graduated in 05/2014
Graduated in 05/2014
Graduated in 01/2014
Graduated in 05/2015
Passed prelim-exam
Passed prelim-exam
Passed prelim-exam
Passed prelim-exam
Graduated in 05/2016
Graduated in 12/2015
RESEARCH ACTIVITIES:
I. Major Areas of Research Interest:
Clinical Epidemiology, Epidemiology of Cardiovascular Diseases, Epidemiology of Cancer, Health Services Research,
Outcomes Research, Breast Cancer Outcomes Research, Nationwide Medicare Claims-Based Research, Disease
Registries (cancer and stroke), Patterns of Care Studies, Evaluating the Effectiveness of Health Services and Therapies,
Comparative Effectiveness Research on Health Services/Therapies, Disparities in Healthcare and Outcomes, and
Postmarketing Drug Surveillance of Adverse-Effects or Toxicities.
II. Research Grant Support:
Active Grants:
1.
Grant Title: “Comparative Effectiveness and Cost Effectiveness of Cancer Chemotherapy”
PI: Du, Xianglin L. at UT-SPH; Agency: AHRQ; Type: R01-HS018956-01A1;
Period: 04/01/12 - 01/31/17; Total cost: $880,026; Effort: 25%.
Role: PI.
2.
Grant Title: “Impact of Health Insurance on Racial Disparities in Cancer Screening, Diagnosis, Treatment and
Survival in Texas”
PI: Du, Xianglin L. at UT-SPH; Agency: CPRIT (Cancer Prevention and Research Institute of Texas);
Type and Grant Number: Individual Investigator Research Award-RP130051;
Period: 06/01/13 - 05/30/17; Total cost: $435,049; Effort: 25%;
Role: PI.
Page 14 of 39
C.V. for Xianglin Du, Ph.D.
3.
Grant Title: “Graduate Training Program in Breast Cancer Disparities at UTSPH”
PI: Dr. Sally Vernon at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;
Type: Training grant - GTDR14300827; Period: 10/30/14 - 10/29/17; Total cost: $135,000; Effort: 5.5%.
Role: Co-Investigator and Mentor.
4.
Grant Title: “Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics”
PI: Dr. Hua Xu; Type and Grant Number: NIH-NCI 1U24 CA194215-01A1;
Period: 09/01/2016 – 08/31/2021; Total costs: $679,300; Effort: 5%;
Role: Co-Investigator.
5.
Grant Title: “Behavioral Science Education Cancer Prevention/Control”
PI: Dr. Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;
Type: 2R25-CA057712-21; Period: 09/01/13 - 08/31/18; Total cost: $537,192 per year;
Effort: Serving on advisory board and mentor with no salary support.
Role: Advisory Board Member and Mentor.
6.
Grant Title: “Research Training in Gasteroenterology”
PI: Dr. Hashem B. El-Serag at Baylor College of Medicine; Agency: NIH/NIDDK;
Type and Grant Number: 2T32DK083266-06; Total cost: $144,277 per year;
Period: 05/01/15 - 04/31/20; Effort: Serving as mentor with no salary support.
Role: Mentor.
Completed Grants:
7.
Grant Title: “Postmarketing Surveillance of Toxicities Associated with Cancer Chemotherapy”
PI: Xianglin Du; Agency: AHRQ; Type: R01-HS016743-01;
Period: 04/01/07-03/31/12; Total cost: $979,451; Effort: 30%.
Role: PI.
8.
Grant Title: “Evaluation of Chemotherapy Claims for Breast Cancer”
PI: Xianglin Du; Agency: NIH/NCI; Type: R01-CA090626-01;
Period: 03/01/01-02/28/06; Total cost: $704,025. Effort: 30% average per year during the study period.
Role: PI.
9.
Grant Title: “Research Supplement for Underrepresented Minorities”
PI: Xianglin Du; Agency: NIH/NCI; Type: R01-CA090626-S1;
Period: 03/01/02-01/31/04; Total cost: $316,394. (Note: This grant was to support Dennie Jones, MD, Associate
Professor of Medicine in the Division of Oncology, Department of Internal Medicine to do clinical epidemiology
and health service research, 50% of his efforts).
Role: PI.
10.
Grant Title: “Impact of Axillary Dissection on Clinical Outcomes of Breast Cancer Surgery”
PI: Xianglin Du; Agency: U.S. Department of Defense; Type: DAMD17-99-1-9379;
Period: 06/01/99-06/31/01; Total cost: $83,802. Effort: 20%.
Role: PI.
11.
Grant Title: “Variations in Breast Cancer Treatment and Mortality”
PI: JS Goodwin; Agency: NIH/NCI; Type: R01-CA871773;
Period: 06/01/99-05/31/03; Total cost: $1,129,632. Effort: 40%.
Role: Co-investigator.
Page 15 of 39
C.V. for Xianglin Du, Ph.D.
12.
Grant Title: “Use of Claims Data to Study Quality of Cancer Care”
PI: JS Goodwin; Agency: NIH/NCI; Type: R01;
Period: 12/01/03-11/30/07; Total cost: $792,750. Effort: 50%.
Role: Co-investigator (moved to the UT-Houston one month after the study was funded).
13.
Grant Title: “Understanding Disparities in Cervical Cancer Survival”
PI: Ann Coker; Agency: NIH/NCI; Type: R21-CA114330;
Period: 04/01/05-03/31/08; Total cost: $392,769; Effort: 5%.
Role: Co-investigator.
14.
Grant Title: “Southwest Center for Occupational and Environmental Health”
PI: Sarah Felknor (former PI: George Delclos); Agency: CDC; Type: 1T42OH008421-01;
Period: 07/01/05-06/30/10; Total Cost: $1,263,791. Effort: 5%.
Role: Co-investigator.
15.
Grant Title: “Evaluating the Utilization of Screening for Hepatocellular Carcinoma”
PI: Dr. Jessica A. Davila; Agency: American Cancer Society; Type: RSGDB-07-010-01-CPHPS;
Period: 01/01/07-12/31/09; Total cost: $352,000; Effort: 15%.
Role: Co-investigator (PI for subcontract with the Baylor College of Medicine at Houston).
16.
Grant Title: “Effective Surveillance Strategies for Melanoma Patients”
PI: Dr. Cormier, Janice at UT-MDACC; Agency: NIH/NCI; Type: R01-CA127328-01A1;
Period: 12/01/07-11/30/10 (NC extension to 11/30/2012); Total cost: $878,508; Effort: 10%.
Role: Co-Investigator (PI for subcontract with the UT-MD Anderson Cancer Center at Houston).
17.
Grant Title: “Batterer Psychological Profile--Preventing Partner Abuse”
PI: Ann Coker; Agency: CDC; Type: R49CE000606;
Period: 03/01/08-08/31/09; Total cost: $285,941; Effort: 5.5%.
Role: Co-investigator (PI for subcontract with the University of Kentucky at Lexington).
18.
Grant Title: “Finding Vulnerable Populations in the Community and Their Special Needs for Public Health
Emergency Preparedness Using Medicaid and Medicare Data”
PI: Liu, Leanne at the Houston Department of Health and Human Services;
Agency: Texas Department of Health and Human Services and Centers for Disease Control & Prevention;
Type: Public Health Emergency Preparedness Award;
Period: 07/01/10-06/31/11; Total cost: $151,793; Effort: 10%;
Role: Co-Investigator.
19.
Grant Title: “Texas Breast Cancer Screening, Early Detection and Treatment Program Outcomes Study”
PI: Dr. Begley, Charles at UT-SPH; Agency: CPRIT (Cancer Prevention and Research Institute of Texas); Type:
Innovation Awards for Cancer Prevention Programs and Services-PP100124;
Period: 08/01/10-01/31/12; Total cost: $138,768; Effort: 10%;
Role: Co-Investigator.
20.
Grant Title: “CERCIT: Comparative Effectiveness Research On Cancer in Texas”
PI: Dr. Goodwin, JS at UTMB; Agency: CPRIT (Cancer Prevention and Research Institute of Texas);
Type: Multi-Investigator Award-RP101207; Period: 8/1/10-7/31/13; Total cost: $4,861,175; Effort: 10%;
Role: Co-Investigator (one core project) and Mentor (on training core).
Page 16 of 39
C.V. for Xianglin Du, Ph.D.
21.
Grant Title: “A Transdisciplinary Training Program for Public Health Researchers and Practitioners Wanting
To Impact Breast Cancer Disparities”
PI: Dr. Luisa Franzini; Agency: Susan J. Komen for the Cure Foundation;
Type: Training grant - KG090010; Period: 08/01/09-07/31/11; Total cost: $337,426; Effort: 5%.
Role: Co-Investigator and Mentor.
22.
Grant Title: “A Transdisciplinary Training Program for Public Health Master and Doctoral Students Wanting to
Impact Breast Cancer Disparities”
PI: Dr. Luisa Franzini at UT-SPH; Agency: Susan J. Komen for the Cure Foundation;
Type: Training grant – KG111378; Period: 08/01/11-07/31/13; Total cost: $269,722; Effort: 5%.
Role: Co-Investigator and Mentor.
23.
Bridge Funding from UT-SPH:
PI: Du, Xianglin L; Period: 04/01/10-06/30/10; Total cost: $8,097.00;
Description: This bridge funding is to cover 50% of a research associate’s 3-month salary for April 1-June 30,
2010.
24.
Grant Title: “East Lancashire Stroke Prevention Project, England”
PI: JK Cruickshank; Agency: East Lancashire Health Authority, England:
Periods: 07/01/93-06/30/95; Total cost: $50,000. Effort: 40%.
Role: Co-investigator.
25.
Grant Title: “Health Services Research in Under-Served Populations”
PI: J.L. Freeman; Agency: Agency for Healthcare Research and Quality (AHRQ);
Type: R24-HS11618; Period: 09/30/01-08/31/04; Effort: Core faculty/mentor with no salary support.
Role: Core Faculty and Mentor for post-doc fellows.
26.
Grant Title: “NRSA Health of Older Minorities”
PI: J. S. Goodwin; Agency: NIH/NIA; Type: T32-AG00270; Period: 07/01/99-06/30/04.
Effort: Core faculty/mentor with no salary support.
Role: Core Faculty and Mentor for post-doc fellows.
27.
Grant Title: “Training of Academic Surgical Oncologists”
PI: Dr. Lee Ellis at UT-MD Anderson Cancer Center; Agency: NIH/NCI;
Type and Grant Number: 5 T32-CA09599-19; Total cost: $525,198 per year;
Period: 2/1/07-1/31/08; Effort: Serving as mentor with no salary support.
Role: Mentor.
28.
Grant Title: “Training of Academic Surgical Oncologists”
PI: Dr. Ellis, Lee at UT-MD Anderson Cancer Center; Agency: NIH/NCI;
Type and Grant Number: 2T32-CA009599-20; Total cost: $500,982 per year;
Period: 02/01/08-01/31/13; Effort: Serving as mentor with no salary support.
Role: Mentor.
29.
Grant Title: “Behavioral Science Education Cancer Prevention/Control”
PI: Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;
Type: 5R25-CA057712-15; Period: 09/01/07-08/31/08; Total cost: $480,910 per year;
Effort: Serving on advisory board and mentor with no salary support.
Role: Advisory Committee Member and Mentor.
Page 17 of 39
C.V. for Xianglin Du, Ph.D.
30.
Grant Title: “Behavioral Science Education Cancer Prevention/Control”
PI: Dr. Mullen, Patricia at UT-School of Public Health; Agency: NIH/NCI;
Type: 2R25-CA057712-16; Period: 09/01/08-08/31/13; Total cost: $480,910 per year;
Effort: Serving on advisory board and mentor with no salary support.
Role: Advisory Board Member and Mentor.
31.
Grant Title: “Research Training in Gasteroenterology”
PI: Dr. Hashem B. El-Serag at Baylor College of Medicine; Agency: NIH/NIDDK;
Type and Grant Number: T32DK083266-01; Total cost: $131,970 per year;
Period: 04/01/10 - 03/31/15; Effort: Serving as mentor with no salary support.
Role: Mentor.
32.
Grant Title: “Effectiveness of Pegfilgrastim Vs. Filgrastim in Elderly Breast Cancer Patients”
PI: Rajan, Suja at UT-SPH; Agency: NIH/NCI; Type and Grant Number: R03-CA181977-01;
Period: 01/01/14 - 12/31/15 (NCE to 12/31/16); Total cost: $152,000; Effort: 5%;
Role: Co-Investigator.
33.
Grant Title: “Repurposing Existing Drugs for Cancer Treatment using Electronic Health Records”
PI: Xu, Hua at UT-School of Biomedical Informatics; Agency: CPRIT;
Type and Grant Number: Recruitment of Rising Stars-CPRIT Scholar-R1307;
Period: 03/01/13 - 02/28/16; Total cost: $2,806,000; Effort: 5%;
Role: Co-Investigator.
PUBLICATIONS:
I. Articles Published in Peer-Reviewed Scientific Journals (in chronological order):
1. Du XL. The Status quo and reform of health centres. Journal of Chinese Rural Health Services Administration.
1984;3(4):17-19.
2. Du XL, Zu S, Zhu A. Assessment of activities of daily living in the elderly. Chinese Journal of Gerontology.
1988;8(3):163-166.
3. Du XL, Zhu A, Zu S. Active life expectancy in the elderly. Chinese Journal of Geriatrics. 1989;8(4):231-233.
4. Parker SG, Du XL, Bardsley MJ, Goodfellow J, Cooper RG, Cleary R, Broughton D, Striet C, James OFW. Measuring
outcomes in care of the elderly. Journal of the Royal College of Physicians of London. 1994;28:428-433.
5. Du XL, Cruickshank K, McNamee R, Saraee M, Sourbutts J, Summers A, Roberts N, Walton E, Holmes S. CaseControl Study of Stroke and the Quality of Hypertension Control in North West England. BMJ. 1997;314:272-276.
6. Du XL, Sourbutts J, Cruickshank K, Summers A, Roberts N, Walton E, Holmes S. A community-based stroke register
in a high risk area for stroke in north west England. Journal of Epidemiology and Community Health. 1997;51:472-478.
7. Du XL, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer.
Breast Cancer Research and Treatment. 1999;53(2):137-144.
8. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of
the linked Medicare and SEER data. Journal of Clinical Epidemiology. 1999;52(5):463-470.
Page 18 of 39
C.V. for Xianglin Du, Ph.D.
9. Du XL, Freeman JL, Freeman DH, Syblik DA, Goodwin JS. Temporal and regional variation in the use of breast
conserving surgery and radiotherapy for older women with early stage breast cancer from 1983 to 1995. Journal of
Gerontology (Medical Sciences). 1999;54(9):474-478.
10. Du XL. Prevalence, treatment, control and awareness of high blood pressure and the risk of stroke in north west
England. Preventive Medicine. 2000;30(4):288-294.
11. Du XL, McNamee R, Cruickshank K. Stroke risk from multiple risk factors combined with hypertension: a primary
care based case-control study in a defined population of northwest England. Annals of Epidemiology. 2000;10(6):380388.
12. Du XL, Freeman DH, Syblik DA. What drove changes in the use of breast conserving surgery for breast cancer since
the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Research
and Treatment. 2000;62(1):71-79.
13. Du XL, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare
claims data for surgical treatment of breast cancer. Medical Care. 2000;38(7):719-727.
14. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: Findings from Medicare
claims data. Journal of Clinical Oncology. 2001;19(5):1455-1461.
15. Du XL, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996.
Cancer. 2001;92(4):730-737. PMCID: PMC2567284 (funded by NCI).
*16. Otiniano ME, Black SA, Ray LA, Du XL, Markides KS. Correlates of diabetic complications in Mexican American
elders. Ethnicity & Disease. 2002;12(2):252-258.
*17. Otiniano ME, Lorimor R, MacDonald E, Du XL. Common fraud experienced by the elderly: Findings from a 1998
survey in Houston, Texas. Texas Medicine. 2002;98(10):46-50.
18. Du XL, Freeman JL, Nattinger AB, Goodwin JS. Survival of women after breast conserving surgery for early stage
breast cancer. Breast Cancer Research and Treatment. 2002;72(1):23-31.
19. Du XL, Osborne C, Goodwin JS. Population-Based Assessment of Hospitalizations for Toxicity from Chemotherapy
in Older Women with Breast Cancer. Journal of Clinical Oncology. 2002;20(24):4636-4642. PMCID: PMC2566741
(funded by NCI).
20. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between Consensus Recommendations and
Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer. Annals of Internal Medicine.
2003;138(2):90-97. PMCID: PMC2566742 (funded by NCI).
*21. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic Mexican
American Elders: Incidence, Prevalence and Predictive Factors. Journal of Diabetes and Its Complications.
2003;17(2):59-65.
*22. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on Disability,
Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. Archives of Physical
Medicine and Rehabilitation. 2003;84(5):725-730.
*23. Otiniano ME, Ottenbacher K, Markides KS, Ray LA, Du XL. Self-Reported Heart Attack in Mexican American
Elders: Examination of Incidence, Prevalence, and 7-year Mortality. Journal of the American Geriatrics Society.
2003;51(7):923-929.
Page 19 of 39
C.V. for Xianglin Du, Ph.D.
*24. Otiniano ME, Markides KS, Ottenbacher K, Ray LA, Du XL. Self-Reported Diabetic Complications and 7-year
Mortality in Mexican American Elders: Findings from a Community-Based Study of Five Southwestern States. Journal of
Diabetes and Its Complications. 2003;17(5):243-248.
25. Du XL, Key CR, Osborne C. Community-Based Assessment of Adjuvant Hormone Therapy in Women with Breast
Cancer, 1991-1997. Breast Journal. 2004;10(5):433-439. PMCID: PMC2566743 (funded by NCI).
*26. Otiniano ME, Du XL, Maldonado MR, Ray LA, Markides KS. Effect of metabolic syndrome on heart attack and
mortality in Mexican-American elderly persons: findings of 7-year follow-up from the Hispanic established population
for the epidemiological study of the elderly. Journal of Gerontology (Medical Sciences). 2005;60(4):466-70.
27. Osborne C, Ostir GV, Du XL, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis,
treatment, and survival of older women with breast cancer. Breast Cancer Research and Treatment. 2005;93(1):41-7.
*28. Cormier JN, *Xing Y, Ding M, Lee J, Mansfield P, Gershenwald J, Ross M, Du XL. Population-Based Assessment
of Surgical Treatment Trends for Patients with Melanoma in the Era of Sentinel Lymph Node Biopsy. Journal of Clinical
Oncology. 2005;23(25):6054-6062.
29. Du XL, Jones DV, Zhang D. Effectiveness of Adjuvant Chemotherapy for Node-Positive Operable Breast Cancer in
Older Women. Journal of Gerontology (Medical Sciences). 2005;60(9):1137-1144. (A guest editorial was invited
specifically for this article). PMCID: PMC2567100 (funded by NCI).
30. Du XL, Chan W, Giordano S, Geraci JM, Delclos GL, Burau K, Fang S. Variation in Modes of Chemotherapy
Administration for Breast Carcinoma and Association with Hospitalization for Chemotherapy-related Toxicity. Cancer.
2005;104(5):913-924. PMCID: PMC2566845 (funded by NCI).
31. Du XL, Lairson DR, Begley CE, Fang S. Temporal and Geographic Variation in the Use of Hematopoietic Growth
Factors in Older Women Receiving Breast Cancer Chemotherapy: Findings from a Large Population-Based Cohort.
Journal of Clinical Oncology. 2005;23(34):8620-8628. PMCID: PMC2572993 (funded by NCI).
32. Du XL, Key CR, Dickie L, Darling R, Delclos GL, Waller K, Zhang D. Information on Chemotherapy and Hormone
Therapy from Tumor Registry Had Moderate Agreement with Chart Reviews. Journal of Clinical Epidemiology.
2006;59(1):53-60. PMCID: PMC2567281 (funded by NCI).
33. Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External Validation of Medicare Claims for Breast
Cancer Chemotherapy Compared with Medical Chart Reviews. Medical Care. 2006;44(2):124-131. PMCID:
PMC2567101 (funded by NCI).
34. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparity and
Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate Carcinoma:
Findings From a Large Community-Based Cohort. Cancer. 2006;106(6):1276-1285.
35. Coker AL, Du XL, Fang S, Eggleston K. Socioeconomic Status and Cervical Cancer Survival among Older Women:
Findings from the SEER-Medicare Linked Data Cohorts. Gynecologic Oncology. 2006;102(2):278-284.
36. Sanderson M, Coker AL, Adriana P, Du XL, Peltz G, Fadden MK. A Multilevel Analysis of Socioeconomic Status
and Prostate Cancer Risk. Annals of Epidemiology. 2006;16(12):901-907.
37. Cormier JN, *Xing Y, Ding M, Lee J, Mansfield P, Gershenwald J, Ross M, Du XL. Ethnic Differences among
Patients with Cutaneous Melanoma. Archives of Internal Medicine. 2006;166(17):1907-1914.
Page 20 of 39
C.V. for Xianglin Du, Ph.D.
38. Du XL, Gor BJ. Racial Disparities and Trends in Radiation Therapy After Breast-Conserving Surgery for Early-Stage
Breast Cancer in Women, 1992 to 2002. Ethnicity & Disease. 2007;17(1):122-128. PMCID: PMC2566852 (funded by
NCI).
*39. Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL. Variations in Chemotherapy and Radiation
Therapy in a Large Nationwide and Community-Based Cohort of Elderly Patients with Non-Hodgkin’s Lymphoma.
American Journal of Clinical Oncology. 2007;30(2):163-171.
40. Du XL, Meyer TE, Franzini L. Meta-Analysis of Racial Disparities in Survival in Association with Socioeconomic
Status among Men and Women with Colon Cancer. Cancer. 2007;109(11):2161-2170.
*41. Rohatgi N, Du XL, Coker AL, Moye L, Wang M, Fang S. Chemotherapy and Survival for Patients with Multiple
Myeloma: Findings from a Large Nationwide and Population-Based Cohort. American Journal of Clinical Oncology.
2007;30(5):540-548.
*42. Holmes L, Chan W, Jiang Z, Du XL. Effectiveness of Androgen Deprivation Therapy in Prolonging Survival of
Older Men Treated for Locoregional Prostate Cancer. Prostate Cancer & Prostatic Diseases. 2007;10(4):388-95.
43. Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus M. Racial Disparities and Socioeconomic Status
in Association with Survival in a Large Population-Based Cohort of Elderly Patients with Colon Cancer. Cancer.
2007;110(3):660-669.
*44. Cabanillas ME, Lu H, Fang S, Du XL. Elderly Patients with Non-Hodgkin’s Lymphoma Who Receive
Chemotherapy are at Higher Risk for Osteoporosis and Fractures. Leukemia & Lymphoma. 2007;48(8):1514-21.
45. Du XL, Fox EE, Lai D. Competing Causes of Death for Women with Breast Cancer and Change Over Time From
1975 to 2003. American Journal of Clinical Oncology. 2008;31(2):105-116. PMCID: PMC2570158 (funded by NCI).
46. Du XL, Fang S, Meyer TE. Impact of Treatment and Socioeconomic Status on Racial Disparities in Survival among
Older Women with Breast Cancer. American Journal of Clinical Oncology. 2008;31(2):125-132. PMID: 18391595
(funded by AHRQ).
47. Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic Differences in Socioeconomic Status, Diagnosis,
Treatment and Survival Among Older Women with Epithelial Ovarian Cancer. International Journal of Gynecological
Cancer. 2008;18(4):660-669. PMID: 17892451 (funded by AHRQ).
**48. Liu L, Coker AL, Du XL, Cormier JN, Ford CE, Fang S. Long-Term Survival after Radical Prostatectomy
Compared to Other Treatments in Older Men with Local or Regional Prostate Cancer. Journal of Surgical Oncology.
2008;97(7):583-591. PMID: 18381603 (funded by AHRQ).
49. Zhou Y, Wang H, Romaguera JE, Zhang Y, Fang W, Delasalle KB, Yi LK, Du XL, Wang M. Incidence Trends of
Mantle Cell Lymphoma in the United States between 1992 and 2004. Cancer. 2008:113(4):791-798. PMID: 18615506
(funded by AHRQ).
*50. Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic Variations in Diagnosis, Treatment, Socioeconomic Status
and Survival in Elderly Patients with Non-Hodgkin’s Lymphoma. Cancer. 2008;113(11):3231-3241. PMID: 18937267
(funded by AHRQ).
*51. White A, Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities and Treatment Trends in a
Large Cohort of Elderly African Americans and Caucasians with Colorectal Cancer, 1991 to 2002. Cancer.
2008;113(12):3400-3409. PMID: 18932248 (funded by AHRQ and NCI).
Page 21 of 39
C.V. for Xianglin Du, Ph.D.
52. Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic Disparities in Cervical Cancer Survival among Medicare
Eligible Women in a Multi-Ethnic Population. International Journal of Gynecological Cancer. 2009;19(1):13-20. PMID:
19258935 (funded by NCI).
*53. Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, Burau KD, Du XL. Racial Disparities and Treatment
Trends in a Large Cohort of Elderly Black and White Patients with Non-Small Cell Lung Cancer. Cancer.
2009;115(10):2199-2211. PMID: 19365824 (funded by AHRQ).
*54. Taylor LG, Canfield S, Du XL. Review of Major Adverse Effects of Androgen Deprivation Therapy in Men with
Prostate Cancer. Cancer. 2009;115(11):2388-2399. PMID: 19399748 (funded by AHRQ).
*55. Bhargava A, Du XL. Racial and Socioeconomic Disparities in Adjuvant Chemotherapy for Node-Positive Operable
Breast Cancer in Older Women. Cancer. 2009;115(13):2999-3008. PMID: 19452539 (funded by AHRQ).
*56. Holmes L, Chan W, Jiang Z, Ward D, Essien EJ, Du XL. Impact of Androgen Deprivation Therapy on Racial/Ethnic
Disparities in Survival of Older Men Treated for Locoregional Prostate Cancer. Cancer Control. 2009;16(2):176-185.
PMCID: PMC2664971 (funded by NCI).
*57. Badgwell B, Chang G, Rodriguez-Bigas M, Smith K, Lupo P, Frankowski F, Delclos G, Du XL, Cormier J.
Management and Outcomes of Anorectal Infection in the Cancer Patients. Annals of Surgical Oncology.
2009;16(10):2752-8. PMID: 19649556 (not funded by NIH).
58. Stuff JE, *LaCour M, Du XL, Franklin F, Liu Y, Hughes S, Peters R, Nicklas TA. The Prevalence of Food Insecurity
and Associated Factors among Households with Children in Head Start Programs in Houston, Texas and Birmingham,
Alabama. Race, Gender & Class. 2009;16:31-47. (not funded by NIH).
*59. Nurgalieva Z, Liu CC, Du XL. Risk of Hospitalizations Associated with Adverse-Effects of Chemotherapy in a
Large Community-based Cohort of Elderly Women with Ovarian Cancer. International Journal of Gynecological Cancer.
2009;19(8):1314-21. PMID: 19417586 (funded by AHRQ).
*60. Hardy D, Xia R, Liu CC, Cormier JN, Nurgalieva Z, Du XL. Racial Disparities and Survival for Non-Small Cell
Lung Cancer in a Large Cohort of Black and White Elderly Patients. Cancer. 2009;115(20):4807-4818. PMID: 19626650
(funded by AHRQ).
61. Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Chan W, Hardy D, Burau KD. Cardiac Toxicity Associated with
Anthracycline-Containing Chemotherapy in Older Women with Breast Cancer. Cancer. 2009;115(22):5296-5308.
[Erratum in: Cancer. 2009;115:5849-51]. PMID: 19672997 (funded by AHRQ).
62. Du XL, Xia R, Hardy D. Relationship between Chemotherapy Use and Cognitive Impairments in Older Women with
Breast Cancer: Findings from a Large Population-Based Cohort. American Journal of Clinical Oncology.
2010;33(6):533-43. PMID: 20023570 (funded by AHRQ).
*63. Nurgalieva Z, Xia R, Liu CC, Burau KD, Hardy D, Du XL. Risk of Chemotherapy-induced Peripheral Neuropathy
in Large Population-based Cohorts of Elderly Patients with Breast, Ovarian and Lung Cancer. American Journal of
Therapeutics. 2010;17(2):148-158. PMID: 19417586 (funded by AHRQ).
*64. Hardy D, Cormier JN, Xing Y, Liu CC, Xia R, Du XL. Chemotherapy-Associated Toxicity in a Large Cohort of
Patients with Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 2010;5(1):90-98. PMID: 19884853 (funded by
AHRQ).
Page 22 of 39
C.V. for Xianglin Du, Ph.D.
*65. Guadagnolo BA, Liu CC, Cormier JN, Du XL. Evaluation of Trends in the Use of Intensity Modulated Radiation
Therapy for Head and Neck Cancer from 2000 through 2005: Socioeconomic Disparity and Geographic Variation in a
Large Population based Cohort. Cancer. 2010;116(14):3505-12. PMID: 20564123 (funded by AHRQ).
66. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Utilization of Screening for
Hepatocellular Carcinoma in the United States. Hepatology. 2010;52(1):132-41. PMID: 20578139 (funded by American
Cancer Society).
67. Du XL, Liu CC. Racial/Ethnic Disparities in Socioeconomic Status, Diagnosis, Treatment and Survival among
Medicare-insured Men and Women with Head and Neck Cancer. Journal of Health Care for the Poor and Underserved.
2010;21(3):913-930. PMID: 20693735 (funded by AHRQ).
*68. White A, Vernon SW, Franzini L, Du XL. Disparities in Colorectal Cancer Survival: To What Extent Are Racial
Disparities Explained by Differences in Treatment, Tumor or Hospital Characteristics? Cancer. 2010;116(19):4622-31.
PMCID: PMC2946464 (funded by NCI).
*69. Hardy D, Liu CC, Cormier JN, Xia R, Du XL. Cardiac Toxicity in Association with Chemotherapy and Radiation
Therapy in a Large Cohort of Older Patients with Non-Small Cell Lung Cancer. Annals of Oncology. 2010;21(9):182533. PMID: 20211871 (funded by AHRQ).
***70. Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Gottschalk AM, Bollard CM, Brenner
MK, Krance RA. The Costs and Cost-Effectiveness of Allogeneic Peripheral Blood Stem Cell Transplantation versus
Bone Marrow Transplantation in Pediatric Patients with Acute Leukemia. Biology of Blood and Marrow Transplantation.
2010;16:1272-81. PMID: 20348004 (not funded by NIH).
*71. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Comparative Effectiveness of White Blood Cell Growth
Factors on Neutropenia, Infection, and Survival in Older People with Non-Hodgkin's Lymphoma Treated with
Chemotherapy. Journal of the American Geriatrics Society. 2010;58(10):1885-95. PMID: 20840455 (funded by AHRQ).
*72. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute
myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma.
Cancer. 2010;116(22):5279-89. PMID: 20665502 (funded by AHRQ).
*73. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Cost-effectiveness of white blood cell growth factor use
among a large nationwide cohort of elderly non-Hodgkin’s lymphoma patients treated with chemotherapy. Value in
Health. 2011;14(2):253-262. PMID: 21402294 (funded by AHRQ).
***74. Lin YF, Lairson DR, Chan W, Du XL, Heslop HE, Brenner MK, Krance RA. Children with Acute Leukemia: A
Comparison of Outcomes from Allogeneic Blood Stem Cell and Bone Marrow Transplantation. Pediatric Blood and
Cancer. 2011;56(1):143-51. PMID: 21108446 (not funded by NIH).
*75. Liu CC, Xia R, Guadagnolo A, Cormier JN, Du XL. Risk of Xerostomia in Association with the Receipt of
Radiation Therapy in Older Patients with Head and Neck Cancer. American Journal of Therapeutics. 2011;18(3):206215. PMID: 20068441 (funded by AHRQ).
*76. Nurgalieva Z, Liu CC, Du XL. Chemotherapy Use and Risk of Bone Marrow Suppression in a Large PopulationBased Cohort of Older Women with Breast and Ovarian Cancer. Medical Oncology. 2011;28(3):716-25. PMID:
20361359 (funded by AHRQ).
*77. Hu CY, Delclos GL, Chan W, Du XL. Assessing the Initiation and Completion of Adjuvant Chemotherapy in a
Large Nationwide and Population-Based Cohort of Elderly Patients with Stage III Colon Cancer. Medical Oncology.
2011;28(4):1062-1074. PMID: 20714945 (funded by AHRQ).
Page 23 of 39
C.V. for Xianglin Du, Ph.D.
*78. Hu CY, Delclos GL, Chan W, Du XL. Post-Treatment Surveillance in a Large Cohort of Colon Cancer Patients.
American Journal of Managed Care. 2011;17:329-336. PMID: 21718080 (funded by AHRQ).
*79. Cheng L, Eng C, DeJesus Y, Nieman LZ, Kapadia AS, Du XL. Trends in Colorectal Cancer Incidence by Anatomic
Site and Disease Stage in the United States from 1976 to 2005. American Journal of Clinical Oncology. 2011;34(6):57380. PMID: 21217399 (funded by AHRQ).
*80. White A, Coker AL, Du XL, Eggleston KS, Williams M. Racial/ethnic disparities in survival among men diagnosed
with prostate cancer in Texas. Cancer. 2011;117(5):1080-1088. PMID: 21061357 (not funded by NIH).
***81. Hosain MGM, Sanderson M, Du XL, Chan W, Strom S. Racial/ethnic differences in predictors of PSA screening
in a tri-ethnic population. Central European Journal of Public Health. 2011;19:30-34. PMID: 21526653 (not funded by
NIH).
*82. Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities in the use of hospice services
according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer.
2011;117 (7):1506-1515. PMID: 21425152 (funded by AHRQ).
83. *Clague JN, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV, Henderson KD, Ursin G, West DW, Chang S, Delclos
G, Du XL, Forman MR, Bernstein L. Menopausal Hormone Therapy Does not Influence Lung Cancer Risk: Results from
the California Teachers Study. Cancer Epidemiology, Biomarkers & Prevention. 2011;20(3):560-4. PMID: 21266521
(funded by NCI).
*84. White A, Vernon SW, Franzini L, Du XL. Racial and Ethnic Disparities in Colorectal Cancer Screening Persisted
Despite Expansion of Medicare's Screening Reimbursement. Cancer Epidemiology, Biomarkers & Prevention.
2011;20(5):811-817. PMID: 21546366 (funded by NCI).
85. Du XL, Xia R, Burau K, Liu CC. Cardiac Risk Associated with the Receipt of Anthracycline and Trastuzumab in a
Large Nationwide Cohort of Older Women with Breast Cancer, 1998-2005. Medical Oncology. 2011;28(supplement
1):S80-90. PMID: 20967512 (funded by AHRQ).
86. Du XL, Lin CC, Johnson NJ, Altekruse S. Effects of Individual-Level Socioeconomic Factors on Racial Disparities in
Cancer Treatment and Survival: Findings from the National Longitudinal Mortality Study, 1979-2003. Cancer.
2011;117(14):3242-51. PMID: 21264829 (funded by NCI and Census Burau).
*87. Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities and length-of-stay in hospice in
an elderly cohort with non-small cell lung cancer. Palliative Medicine. 2012;26(1):61-71. PMID: 21606129 (funded by
AHRQ).
**88. Sail K, Franzini L, Lairson DR, Du XL. Differences in Treatment and Survival among African American and
Caucasian Women with Early Stage Operable Breast Cancer. Ethnicity and Health. 2012;17(3):309-323. PMID:
22066691 (funded by AHRQ and Susan Komen for the Cure).
***89. Sail K, Franzini L, Lairson DR, Du XL. Clinical and Economic Outcomes Associated With Adjuvant
Chemotherapy In Elderly Patients With Early Stage Operable Breast Cancer. Value in Health. 2012;15(1):72-80. PMID:
22264974 (funded by Susan Komen for the Cure Foundation).
*90. Abotchie PN, Vernon SW, Du XL. Gender differences in colorectal cancer incidence in the United States, 19752006. Journal of Women’s Health. 2012;21(4):393-400. PMID: 22149014 (funded by NCI).
Page 24 of 39
C.V. for Xianglin Du, Ph.D.
*91. Hu CY, Chan W, Delclos G, Du XL. Adjuvant Chemotherapy and Risk of Gastrointestinal, Hematological and
Cardiac Toxicities for Stage III Colon Cancer among Elderly Patients. American Journal of Clinical Oncology.
2012;35(3):228-236. PMID: 21383605 (funded by AHRQ).
92. Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian A, Kwak L, Rustveld L, Du XL, Wang M. Temporal and
Geographic Variations of Waldenström’s Macroglobulinemia Incidence: A Large Population-Based Study. Cancer.
2012;118(15):3793-3800. PMID: 22139816 (not funded by NIH).
***93. Hosain MGM, Sanderson M, Du XL, Chan W, Strom S. Racial/ethnic differences in treatment discussed, chosen
and received for prostate cancer in a tri-ethnic population. American Journal of Men's Health. 2012;6(03):249-257.
PMID: 22419652 (not funded by NIH).
94. Cen P, Banki F, Cheng L, Khalil K, Du XL, Fallon MB, Amato R, Kaiser LR. Changes in Age, Stage distribution and
Survival of Patients with Esophageal Adenocarcinoma over Three Decades in the United States. Annals of Surgical
Oncology. 2012;19(5):1685-91. PMID: 22130619 (not funded by NIH).
*95. Cen P, Liu CC, Du XL. Comparison of Toxicity Profiles of Fluorouracil versus Oxaliplatin Regimens in a Large
Population-based Cohort of Older Patients with Colorectal Cancer. Annals of Oncology. 2012;23(6):1503-11. PMID:
22021820 (funded by AHRQ).
***96. Kowalkowski MA, Hart SL, Du XL, Baraniuk S, Latini DM. Cancer Perceptions: Implications from the 2007
Health Information National Trends Survey. Journal of Cancer Survivorship. 2012;6(3):287-95. PMID: 22457218 (not
funded by NIH).
***97. Wendt JK, Symanski E, Du XL. Estimation of Asthma Incidence Among Low-Income Children in Texas: A
Novel Approach Using Medicaid Claims Data. American Journal of Epidemiology. 2012;176(8):744-50. PMID:
23024134 (funded by NIH/NIOSH).
***98. Panchal J, Lairson D, Chan W, Du XL. Geographic Variation and Socio-demographic Disparity in the Utilization
of Oxaliplatin-containing Chemotherapy in Patients with Stage-III Colon Cancer. Clinical Colorectal Cancer.
2013;12(2):113-121. PMID: 23137529 (funded by AHRQ and CPRIT).
*99. Li N, Du XL, Reitzel L, Xu L, Sturgis E. Impact of enhanced detection on the increase in thyroid cancer incidence
in the US: review of incidence trends by socioeconomic status within the Surveillance, Epidemiology, and End Results
registry, 1980-2008. Thyroid. 2013;23(1):103-110. PMID: 23043274 (not funded by NIH).
*100. Liu L, Wang H, Chen Y, Liu G, Rustveld L, Du XL. Splenic Marginal Zone Lymphoma: a population-based study
on the incidence and survival in the United States from 2001 to 2008. Leukemia and Lymphoma. 2013;54(7):1380-86.
PMID: 23101590 (not funded by NIH).
*101. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy
initiation and completion after surgery on racial disparities in survival among women with breast cancer. Medical
Oncology. 2013;30:419 (pages 1-9). PMID: 23292872 (funded by AHRQ and Komen for the Cure foundation).
***102. Wang GD, Lai DJ, Burau KD, Du XL. Potential gains in life expectancy from reducing heart disease, cancer,
Alzheimer’s disease, kidney disease or HIV/AIDS as major causes of death in the USA. Public Health. 2013;127(4):348356. PMID: 23507421 (not funded by NIH).
***103. Cai Y, Lai D, Waller K, Du XL, Burau K, Symanski E. Statistical Analysis of the Day of the Week Effect on
Births in Harris County, Texas. Journal of Biological Systems. 2013;21(2):1350014 (pages 1-8). (not funded by NIH).
Page 25 of 39
C.V. for Xianglin Du, Ph.D.
104. Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative Effectiveness of Platinum-based Chemotherapy
versus Taxane and Other Regimens for Ovarian Cancer. Medical Oncology. 2013;30(1):440 (pages 1-14). PMID:
23307252 (funded by AHRQ & CPRIT).
105. Du XL, Cai Y, Symanski E. Association between Chemotherapy and Cognitive Impairments in a Large Cohort of
Patients with Colorectal Cancer. International Journal of Oncology. 2013;42(6):2123-2133. PMID: 23563930 (funded by
AHRQ & CPRIT).
106. Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X.
Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival
among Asian Americans with colorectal cancer. British Journal of Cancer. 2013;108:1508-1514. PMID: 23470470 (not
funded by NIH).
*107. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Du XL. Utilization of lymph node dissection, race/ethnicity and
breast cancer outcomes. American Journal of Managed Care. 2013;19(10):805-810. PMID: 24304159 (funded by AHRQ
and Susan Komen for the Cure).
108. Liu P , Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi M. Comparison of clinicopathologic
features, and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. British
Journal of Cancer. 2013;109(5):1302-9. PMID: 23907433 (not funded by NIH).
*109. Nurgalieva Z, Franzini L, Morgan R, Vernon SW, Du XL. Surveillance mammography use after treatment of
primary breast cancer and racial disparities in survival. Medical Oncology. 2013;30(4):691 (pages 1-8). PMID: 23975632
(funded by AHRQ, Susan Komen for the Cure, and CPRIT).
***110. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Assessing
Periodontitis in Populations: A Systematic Review of the Validity of Partial Mouth Examination Protocols. Journal of
Clinical Periodontology. 2013;40(12):1064-71. PMID: 24192071 (not funded by NIH).
***111. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Assessment of
Partial-Mouth Periodontal Examination Protocols for Periodontitis Surveillance. Journal of Clinical Periodontology.
2014;41(9):846-52. PMID: 25041094 (not funded by NIH).
***112. Huo J, Lairson DR, Du XL, Chan W, Buchholz TA, Guadagnolo BA. Survival and cost-effectiveness of hospice
care for metastatic melanoma patients. American Journal of Managed Care. 2014;20(5):366-373. PMID: 25181566 (not
funded by NIH).
113. Lairson DR, Parikh RC, Cormier JN, Du XL. Cost-utility analysis of platinum-based chemotherapy versus taxane
and other regimens for ovarian cancer. Value in Health. 2014;17(1):34-42. PMID: 24438715 (funded by AHRQ).
*114. Tong L, Ahn C, Symanski E, Lai D, Du XL. Temporal trends in the leading causes of death among a large national
cohort of patients with colorectal cancer from 1975 to 2009 in the United States. Annals of Epidemiology.
2014;24(6):411-417. PMID: 24529646 (funded by AHRQ).
*115. Tong L, Ahn C, Symanski E, Lai D, Du XL. Effects of newly developed chemotherapy regimens, comorbidities,
chemotherapy-related toxicity on the changing patterns of the leading causes of death in elderly patients with colorectal
cancer. Annals of Oncology. 2014;25(6):1234-42. PMID: 24681607 (funded by AHRQ).
*116. Tong L, Ahn C, Symanski E, Lai D, Du XL. Relative impact of earlier diagnosis and improved treatment on
survival for colorectal cancer: A US database study among elderly patients. Cancer Epidemiology. 2014;38(6):733-740.
PMID: 25454261 (funded by AHRQ and CPRIT).
Page 26 of 39
C.V. for Xianglin Du, Ph.D.
***117. Wendt JK, Symanski E, Stock TH, Chan W, Du XL. Association of Short-Term Increases in Ambient Air
Pollution and Timing of Initial Asthma Diagnosis among Medicaid-Enrolled Children in a Metropolitan Area.
Environmental Research. 2014;131:50-58. PMID: 24657516 (funded by NIH/NIOSH).
*118. Sheth R, Flescher-Peskin M, Du XL. Duration of Hepatitis B Vaccine Immunity in Pediatric Dialysis Patients.
Pediatric Nephrology. 2014;29(10):2029-37. PMID: 24839216 (not funded by NIH).
119. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy Regimens in Elderly
Patients with Stage III Colon Cancer. PharmacoEconomics. 2014;32(10):1005-13. PMID: 24920195 (funded by AHRQ
and CPRIT).
***120. Kowalkowski MA, Mims MA, Day RS, Du XL, Chan W, Chiao EY. Longer duration of combination
antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans. Cancer
Epidemiology. 2014;38(4):386-92. PMID: 24947588 (funded by NIH).
***121. Kowalkowski MA, Day RS, Du XL, Chan W, Chiao E. Cumulative HIV viremia and non-AIDS-defining
malignancies among a sample of HIV-infected male veterans. Journal of Acquired Immune Deficiency Syndromes.
2014;67(2):204-11. PMID: 25078536 (funded by NIH).
*122. Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV Jr, Chang S, Delclos GL, Du XL,
Forman MR, Bernstein L. Menopausal Hormone Therapy and Lung Cancer-Specific Mortality Following Diagnosis: The
California Teachers Study. PLoS One. 2014;9(7):e103735. PMID: 25079077 (funded by NIH).
*123. Zhang Y, Fu S, Du XL. Increasing Utilization and Predictors of Hematopoietic Growth Factors in Patients
Diagnosed with Colorectal Cancer: Findings From a Large National Population-based Cohort in the United States, 19922009. Medical Oncology. 2014;31(10):242 (pages 1-11). PMID: 25231751 (funded by AHRQ and CPRIT).
***124. Russell HV, Okcu MF, Kamdar K, Shah MD, Kim E, Swint JM, Chan W, Du XL, Franzini L, Ho V. Algorithm
for analysis of administrative pediatric cancer hospitalization data according to indication for admission. BMC Medical
Informatics and Decision Making. 2014;14(1):88. PMID: 25274165 (funded by CPRIT training grant).
125. Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover Effects of
Estrogen Receptor Status on Breast Cancer-Specific Hazard Rates by Age and Race. PLoS One. 2014 Oct
21;9(10):e110281. PMID: 25333877 (not funded by NIH).
*126. Rajan SS, Cai Y, Yi M, Tsai CL, Du XL. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients
Receiving Chemotherapy: A SEER-Medicare Based Study. American Journal of Clinical Oncology. 2014 July 25. [Epub
ahead of print]. PMID: 25068470 (funded by AHRQ).
***127. Kadakia A, Rajan SS, Abughosh S, Du XL, Johnson ML. CMF-regimen preferred as first-course chemotherapy
for older and sicker women with breast cancer: Findings from a SEER-Medicare based population study. American
Journal of Clinical Oncology. 2015;38(2):165-173. PMID: 23608830 (not funded by NIH).
***128. Huo J, Du XL, Lairson DR, Chan WY, Jiang J, Buchholz TA, Guadagnolo BA. Utilization of Surgery,
Chemotherapy, Radiation Therapy, and Hospice at the End of Life for Patients Diagnosed with Metastatic Melanoma.
American Journal of Clinical Oncology. 2015;38(3):235-41. PMID: 23648436 (not funded by NIH).
*129. Liu Z, Zhang Y, Franzini L, Cormier JN, Chan W, Xu H, Du XL. Trends and Variations in Breast and Colorectal
Cancer Incidence from 1995 to 2011: A Comparative Study between the Texas Cancer Registry and National Cancer
Institute’s Surveillance, Epidemiology and End Results Data. International Journal of Oncology. 2015;46(4):1819-1826.
PMID: 25672365 (funded by CPRIT).
Page 27 of 39
C.V. for Xianglin Du, Ph.D.
130. Du XL, Zhang Y, Parikh RC, Lairson DR, Cai Y. Comparative Effectiveness of Chemotherapy Regimens in
Prolonging Survival for Two Large Population-based Cohorts of Elderly Adults with Breast and Colon Cancer in 19922009. Journal of the American Geriatrics Society. 2015;63(8):1570-82. PMID: 26200214 (funded by AHRQ & CPRIT).
*131. Poonawalla IB, Lairson DR, Chan W, Piller LB, Du XL. Cost-Effectiveness of Neoadjuvant Chemotherapy versus
Primary Surgery in Elderly Patients with Advanced Ovarian Cancer. Value in Health. 2015;18(4):387-395. PMID:
26091592 (funded by AHRQ).
*132. Ludwig MS, Kuban DA, Du XL, Lopez DS, Yamal JM, Strom SS. The Role of Androgen Deprivation Therapy on
Biochemical Failure and Distant Metastasis in Intermediate-Risk Prostate Cancer: A Retrospective Study of the Effects of
Radiation Dose Escalation. BMC Cancer. 2015;15(1):190. PMID: 25885406 (not funded by NIH).
*133. Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. Assessing the Optimum use of AndrogenDeprivation Therapy in High Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. American
Journal of Men's Health. 2015 April 19. [Epub ahead of print]. PMID: 25891393 (not funded by NIH).
*134. Wang X, Du XL. Socio-demographic and Geographic Variations in the Utilization of Hormone Therapy in Older
Women with Breast Cancer after Medicare Part-D Coverage. Medical Oncology. 2015;32(5):154 (pages 1-14). PMID:
25837434 (funded by AHRQ and CPRIT).
135. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Treatments for Advanced NonSmall Cell Lung Cancer. American Journal of Pharmacy Benefits. 2015;7(6):271-279. (funded by AHRQ and CPRIT).
*136. Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and
Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal of Health Care for the Poor and
Underserved. 2015;26(4):1336-58. PMID: 26548682 (funded by CPRIT).
*137. Poonawalla IB, Parikh RC, Du XL, VonVille HM, Lairson DR. Cost-Effectiveness of Chemotherapeutic Agents
and Targeted Biologics in Ovarian Cancer: A Systematic Review. PharmacoEconomics. 2015;33(11):1155-85. (Invited
systematic review). PMID: 26072142 (funded by AHRQ).
138. Du XL, Zhang Y. Risks of Venous Thromboembolism, Stroke, Heart Disease and Myelodysplastic Syndrome
Associated with Hematopoietic Growth Factors in a Large Population-based Cohort of Patients with Colorectal Cancer.
Clinical Colorectal Cancer. 2015;14(4):e21-31. PMID: 26119923 (funded by AHRQ and CPRIT).
139. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Effectiveness of Chemotherapy for Breast Cancer and
Age Effect in Older Women. Value in Health. 2015;18(8):1070-78. PMID: 26686793 (funded by AHRQ and CPRIT).
***140. Park M, Lai D, Du XL, Delclos GP, Moye LA. General Linear Models in a Missing Outcome Environment of
Clinical Trials Incorporating with Splines for Time-Invariant Continuous Adjustment. American Journal of Biostatistics.
2015;5(1):7-51. DOI: 10.3844/amjbsp.2015.7.51. (not funded by NIH).
141. Du XL, Parikh RC, Lairson DR. Racial and Geographic Disparities in the Patterns of Care and Costs at the End of
Life for Patients with Lung Cancer in 2007-2010 after the 2006 Introduction of Bevacizumab. Lung Cancer.
2015;90(3):442-250. PMID: 26439736 (funded by AHRQ and CPRIT).
142. Du XL, Zhang Y, Hardy D. Temporal and Geographic Variations in the Receipt of Colony-Stimulating Factors and
Erythropoiesis-Stimulating Agents in a Large Retrospective Cohort of Older Women with Breast Cancer from 2000 to
2009. American Journal of Therapeutics. 2016;23(2):e411-e421. PMID: 25756469 (funded by AHRQ and CPRIT).
*143. Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Impact of Hematopoietic Growth Factors on Blood
Transfusion Needs, Incidence of Neutropenia and Overall Survival among Elderly Advanced Ovarian Cancer Patients
Page 28 of 39
C.V. for Xianglin Du, Ph.D.
Treated With Chemotherapy. International Journal of Gynecological Cancer. 2016;26(1):95-103. PMID: 26509851
(funded by AHRQ).
***144. Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of Treatment Sequences in Chemotherapy and Targeted
Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-based Cohort of Elderly Patients. Drugs
Real World Outcomes. 2016;3(1):69-82. PMID: 27073759 (funded by AHRQ and CPRIT).
**145. Panchal J, Lairson D, Chan W, Du XL. Geographic Variation in Oxaliplatin-Chemotherapy and Survival in Colon
Cancer Patients. American Journal of Therapeutics. 2016;23(3):e720-9. PMID: 24368611 (funded by AHRQ).
***146. Huo J, Lairson DR, Du XL, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Hospital Case Volume is
Associated With Improved Survival for Patients With Metastatic Melanoma. American Journal of Clinical Oncology.
2016;39(5):491-496. PMID: 24755661 (not funded by NIH).
*147. Farias AJ, Du XL. Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women
with hormone receptor-positive breast cancer enrolled in Medicare Part D. Medical Oncology. 2016;33(2):19 (pages 114). PMID: 26786154; PMCID: PMC4934890 (funded by NCI, AHRQ and CPRIT).
***148. Tran DT, Gay I, Du XL, Fu Y, Bebermeyer RD, Newmann A, Streckfus C, Chan W, Walji M. Partial-mouth
periodontal examination protocol for estimating periodontitis extent and severity in a United States population. Clinical
and Experimental Dental Research. 2016;2(1):73-79. DOI: 10.1002/cre2.24. (not funded by NIH).
149. Du XL, Zhang Y, Hardy D. Associations between Hematopoietic Growth Factors and Risks of Venous
Thromboembolism, Stroke, Heart Disease and Myelodysplastic Syndrome: Findings from a Large Population-based
Cohort of Women with Breast Cancer. Cancer Causes and Control. 2016;27(5):695-707. PMID: 27059219 (funded by
AHRQ and CPRIT).
*150. Liu Z, Zhang K, Du XL. Risks of Developing Breast and Colorectal Cancer in Association with Incomes and
Geographic Locations in Texas: a Retrospective Cohort Study. BMC Cancer. 2016;16(1):294. doi: 10.1186/s12885-0162324-z.. PMID: 27118258 (funded by CPRIT and AHRQ).
151. Li D, Du XL, Ren Y, Liu P, Li S, Yang J, Lv M, Chen L, Wang X, Li E, Yang J, Yi M. Comparative Analysis of
Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer. PLoS One. 2016
May 31;11(5):e0156617. PMID: 27244238 (not funded by NIH).
*152. Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Use of Hematopoietic Growth Factors and Risk of
Thromboembolic and Pulmonary Toxicities in Elderly Patients with Advanced Ovarian Cancer. Women's Health Issues.
2016;26(5):574-583. PMID: 27365286 (funded by AHRQ).
***153. Parikh RC, Du XL, Morgan RO, Lairson DR. Cost Effectiveness of Treatment Sequences of Chemotherapies
and Targeted Biologics for Elderly Metastatic Colorectal Cancer Patients. Journal of Managed Care and Specialty
Pharmacy. 2016;In press. PMID: (funded by AHRQ and CPRIT).
*154. Farias AJ, Du XL. The association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy
adherence among Medicare breast cancer patients. Journal of Clinical Oncology. 2016;In press. PMID: ; PMCID:
(funded by NCI, AHRQ and CPRIT).
(Note: Of the 154 peer-reviewed articles, 150 were original articles and 4 (#40, 54, 110 & 137) were review articles.
*First author of the article was student or fellow or junior faculty whom I supervised/advised and I served as
corresponding author for the majority of these articles.
**First author of the article was student and I served on the committee and served as corresponding author.
***First author of the article was student and I served as the thesis/dissertation committee member.)
Page 29 of 39
C.V. for Xianglin Du, Ph.D.
II. Research Letters, Editorial or Commentary Published in Scientific Journals or Professional Websites:
155. Du XL. Increase in the Use of Breast-Conserving Surgery. JAMA. 1999;282(4):326-327. PMID: PM10432025
(funded by NCI).
156. Du XL. Re: Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the
United States: 1975-1999. Journal of the National Cancer Institute. 2003;95:683-5. PMID: PM12734321
(funded by NCI).
157. Du XL, Key CR. Chemotherapy in Women with Breast Cancer. Annals of Internal Medicine. 2003;139(10):868869. (funded by NCI).
158. Du XL. Enhance the FDA’s Postmarketing Drug Surveillance System of Adverse Effects through the Electronic
Healthcare Data. Epidemiology: Open Access. 2012;2(2):e104:1-3. doi:10.4172/2161-1165.1000e104.
(Editorial) (funded by AHRQ).
159. Du XL. Invited Commentary: “Socioeconomic Disparities in Diffuse Large B-Cell Lymphoma Outcomes”.
Expert Comment at http://www.practiceupdate.com/journalscan/9157. April 04, 2014.
160. Tong L, Du XL. Temporal trend in the diabetes-specific death rate among patients with colorectal cancer from
1975 to 2009 in the United States. Annals of Epidemiology. 2014;24(10):790. (Letter to the Editor) PMID:
25154036 (funded by AHRQ).
III. Abstracts Published in Scientific Journals or Professional Websites:
161. Du XL, Zhu A, Zu S. Multidimensional assessment of health care in the elderly. Proceedings of Postgraduate
Dissertations of Anhui Medical University. 1987;6:52-53.
162. Du XL. A five year retrospective study on cancer mortality in Anhui. Acta Anhui Medical University.
1987;22(1):4-5
163. Du XL, Zhu A, Zu S. Comprehensive evaluation of health status and functional well-being in the elderly. Acta
Anhui Medical University. 1988;23(2):146.
164. Du XL, Zhu A, Zu S. Comparative study on life expectancy and active life expectancy. Acta Anhui Medical
University. 1990;25(1):5.
165. Du XL, Bardsley M, Goodfellow J, Streit C, Cooper R, Broughton D, James OFW, Parker SG. Routine
outcomes assessment on a geriatric rehabilitation unit. Age & Ageing. 1992;21(suppl 2):7.
166. Streit C, Parker SG, Du XL, Bardsley M, Goodfellow J, James OFW. Long term outcomes after admission to a
geriatric rehabilitation unit. Age & Ageing. 1993; 22(suppl 2):16-17.
167. Parker SG, Du XL, Goodfellow J, Broughton D, Cleary R, James OFW. Measuring outcomes assessment in
elderly patients in a geriatric day hospital. Age & Ageing. 1993;22(suppl 3):5.
168. Cruickshank JK, Du XL, Redmond P. Poorly managed hypertension in diabetes: the postural drop problem, and
potential for preventing premature stroke and coronary events. Diabetic Medicine. 1995;12 (suppl 2):S41.
169. Du XL, Cruickshank JK, Sourbutts J, Summers A, Roberts N, Walton E, Holmes S, Saraee M, Theodoulidis B.
Prevalence, treatment, control and awareness of high blood pressure among first-ever stroke patients in
Northwest England. Journal of Hypertension. 1996;14(suppl 1):S244.
170. Du XL, Cruickshank JK, McNamee R, Summers A. How far can stroke in routine general practice be prevented?
A case-control study in relation to quality of control of blood pressure in East Lancashire. Journal of
Epidemiology and Community Health. 1996;50:583.
171. Du XL, Cruickshank JK, McNamee R, Summers A. How closely is the risk of stroke related to quality of
hypertension detection and control? A case-control study in East Lancashire. Journal of Hypertension.
1996;14:1503-04.
Page 30 of 39
C.V. for Xianglin Du, Ph.D.
172. Du XL, Cruickshank K, Sourbutts J, Summers A, Roberts N, Walton E and Holmes S. A population’s treatment,
control and awareness of hypertension in relation to stroke risk in northwest England. Annals of Epidemiology.
1998;8:469.
173. Du XL, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the
advantages of the linked Medicare and SEER data. Annals Epidemiology. 1998;8:469.
174. Du XL, McNamee R, Cruickshank K. Stroke risk from multiple risk factors combined with hypertension: a
primary care based case-control study in a defined population of northwest England. American Journal of
Epidemiology. 2000;151(suppl):S36.
175. Du XL, Freeman JL, Nattinger AB, Goodwin JS. The effect of axillary node dissection on survival in women
with early stage breast cancer. Am J Epidemiology. 2000;151(suppl):253.
176. Du XL, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare
claims data. Gerontologist. 2000;40(Special Issue I):344-345.
177. Du XL, Goodwin JS. Increase of Chemotherapy Use in Older Women with Breast Cancer from 1991 to 1996.
Am J Epidemiology. 2001;153(suppl):362.
178. Du XL, Goodwin JS. Using Medicare Data to Examine the Patterns of Chemotherapy Use for Older Women
with Breast Cancer. Am J Epidemiology. 2001;153(suppl):836.
179. Otiniano ME, Du XL, Ray LA, Markides KS. The effect of diabetes combined with stroke on physical
impairment and mortality in elderly Hispanics. Gerontologist. 2001;41(Issue I):249.
180. Du XL, Goodwin JS. Increase of chemotherapy use in older women with breast cancer from 1991 to 1996.
Gerontologist. 2001;41(Special Issue I):337.
181. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic
Mexican American Elders: Incidence, Prevalence and Predictive Factors. Journal of the American Geriatrics
Society. 2002;50(4, supplement):S68.
182. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on
Disability, Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE. J
Am Geriatric Society. 2002;50(4, supplement):S69.
183. Otiniano ME, Du XL, Ottenbacher K, Black SA, Markides KS. Lower Extremity Amputations in Diabetic
Mexican American Elders: Incidence, Prevalence and Predictive Factors. Diabetes. 2002;51(supplement 2):A18.
184. Otiniano ME, Du XL, Ottenbacher K, Markides KS. The Effect of Diabetes Combined with Stroke on
Disability, Self-rated Health and Mortality in Older Mexican Americans: Results from the Hispanic EPESE.
Diabetes. 2002;51(supplement 2):A235.
185. Otiniano ME, Du XL, Ray LA, Ottenbacher K, Markides KS. Heart Attack in Mexican American Elders:
Examination of Incidence, Prevalence, and 7-year Mortality. Gerontologist. 2002;42(Special Issue I):300.
186. Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between Consensus Recommendations
and Actual Community Use of Chemotherapy in Women with Breast Cancer. Gerontologist. 2002;42(Special
Issue I):190-191.
187. Otiniano ME, Markides KS, Ottenbacher K, Ray LA, Du XL. Self-Reported Diabetic Complications and 7-year
Mortality in Mexican American Elders: Findings from a Community-Based Study of Five Southwestern States. J
Am Geriatrics Society. 2003;51(4, supplement):S56.
188. Du XL, Jones D, Goodwin J. Evidence of real-world effectiveness of adjuvant chemotherapy for node-positive
operable breast cancer in old women. Am J Epidemiology. 2003;157(suppl):148.
189. Du XL, Jones DV. Efficacy and effectiveness of adjuvant chemotherapy in old women with node-positive
operable breast cancer. Gerontologist. 2003;43(Special Issue I):141.
190. Cormier JN, Xing Y, Ding M, Ross M, Lee J, Mansfield P, Gershenwald J, Du XL. Population based assessment
of surgical treatment trends for melanoma patients. J Clin Oncol (Meeting Abstracts) 2005;23(June
supplement):7509.
191. Otiniano ME, Ray L, Du XL, Eschbach K, Markides K, Wong R. Migration and Diabetes Control in adult
Mexican men. Journal of the American Geriatrics Society. 2006;54(S4):C43.
192. Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparities
and Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate
Cancer. AcademyHealth Annual Meeting, June 25-27, 2006, Seattle, WA:
http://www.academyhealth.org/arm/awards/abstracts.htm.
Page 31 of 39
C.V. for Xianglin Du, Ph.D.
193. Hosain M, Sanderson M, Du XL, Chan W, Strom S. Racial/Ethnic differences in prostate cancer screening
between Caucasians and Hispanics. 98th American Association for Cancer Research annual meeting, Apr 14-18,
2007; Los Angeles, CA, http://www.aacrmeetingabstracts.org/content/vol2007/1_Annual_Meeting/index.dtl.
194. Zhou Y, Wang H, Zhang Y, Du X, Kwak L, Romaguera J, Wang M. Trend and geographic variations in the
incidence of mantle cell lymphoma in the United States from 1975 to 2003. Proc ASCO. 2007;25(18S):8091.
195. Zhou Y, Wang H, Zhang Y, Du XL, Romaguera J, Wang M. Trend and Geographic Variations in the Incidence
of Mantle Cell Lymphoma in the United States from 1975 to 2003. ASCO Annual meeting, 2007, #9091:
http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Abstracts.
196. Wang M, Zhou Y, Wang H, Yi Q, Zhang Y, Alexanian R, Kwak L, Du X. Trend and geographic variations in
the incidence of Waldenstrom’s Macroglobulinemia in the United States over 17 years from 1988 to 2004.
American Society of Hematology, 49th Annual Meeting, 2007, http://www.abstracts2view.com/hem07/.
197. Zhou Y, Wang H, Du X, Yi Q, Zhang Y, Romaguera J, Wang M. Trend and geographic variations in the
incidence of mantle cell lymphoma in the United States over 30 years from 1975 to 2004. American Society of
Hematology, 49th Annual Meeting, 2007, http://www.abstracts2view.com/hem07/.
198. Du XL, Fang S, Meyer TE. Impact of Treatment and Socioeconomic Status on Racial Disparities in Survival
among Older Women with Breast Cancer. AcademyHealth annual meeting, Orlando, FL, June 3-5, 2007,
http://www.academyhealth.org/2007/abstracts/posters.pdf.
199. Rohatgi N, Du XL, Coker AL, Moye L, Wang M, Fang S. Chemotherapy increases survival in patients with
multiple myeloma. Nature Clinical Practice ONCOLOGY. 2008;5(1).
200. White A, Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities & Trends in the Receipt
of Standard Therapy for Colorectal Cancer in a Large Cohort of African Americans & Caucasians Aged 65
Years & Older. AcademyHealth annual meeting, Washington DC, June 8-10, 2008,
http://www.academyhealth.org/2008/posterabstracts.pdf.
201. Davila JA, Morgan RO, Richardson P, Du XL, McGlynn KA, El-Serag HB. Utilization of Screening for
Hepatocellular Carcinoma in the United States. Digestive Disease Week 2008, San Diego, CA, P-782:
http://download.abstractcentral.com/ddw2008/myddw2008/782.html.
202. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Physician Characteristics are
Significantly Associated with Screening for Hepatocellular Carcinoma in the United States. International Liver
Cancer Association Annual Conference, Chicago, IL, 2008, P-076: http://www.ilcaonline.org/images/conference_area/pdf/ILCA2008_BookofAbstracts.pdf.
203. Song S, Burau KD, Fang S, Wang H, Du XL, Wang L. Ethnic Variations in Diagnosis, Treatment,
Socioeconomic Status and Survival in a Large Population-Based Cohort of Elderly Patients with Non-Hodgkin’s
Lymphoma.Amercian Society of Hematology 50th Annual Meeting, San Francisco, December 6-9, 2008.
http://ash.confex.com/ash/2008/webprogram/Paper1653.html.
204. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Outcomes of Screening for
Hepatocellular Carcinoma in the United States. Digestive Disease Week, Chicago, IL, May 30-June 4, 2009, P739. http://myddw2009.bdmetrics.com/SOW-26650830/739-Outcomes-of-Screening-for-HepatocellularCarcinoma-in-the-United-States/Overview.aspx.
205. White A, Vernon SW, Franzini L, Du XL. Racial/ethnic disparities and trends in screening for colorectal cancer
among Medicare beneficiaries with cancer and those without cancer in SEER areas, 1992–2002. Cancer Prev
Res 2010;3(1 Suppl):B32.
206. Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute
myeloid leukemia or myelodysplastic syndrome among elderly non-Hodgkin's lymphoma patients. Cancer Prev
Res 2010;3(1 Suppl):B129.
207. White A, Vernon SW, Franzini L, Du XL. Disparities in Colorectal Cancer Survival: To What Extent Are Racial
Disparities Explained by Differences in Treatment, Tumor or Hospital Characteristics? American Public Health
Association (138th annual meeting in Denver, CO, November 2010) abstracts.
http://apha.confex.com/apha/138am/webprogram/Paper218115.html.
208. Gruschkus SK, Lairson D, Dunn JK, Risser JM, Du XL. Use of white blood cell growth factors and risk of acute
myeloid leukemia or myelodysplastic syndromes among elderly non-Hodgkin's lymphoma patients. Value in
Health. 2010;13(3):page 23 (abstract # PCN1). http://onlinelibrary.wiley.com/doi/10.1111/j.15244733.2010.00722_1.x/pdf.
Page 32 of 39
C.V. for Xianglin Du, Ph.D.
209. Gruschkus SK, Lairson D, Dunn JK, Risser JM, Du XL. Cost-effectiveness of white blood cell growth factor use
among elderly non-Hodgkin's lymphoma patients treated with chemotherapy. Value in Health. 2010;13(3):page
38 (abstract # PCN76). http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00722_1.x/pdf.
210. Sail K, Franzini L, Du XL, Lairson D. Racial disparities associated with treatment and survival in elderly
patients with early stage operable breast cancer. Value in Health. 2010;13(3):page 48 (abstract # PCN129).
http://onlinelibrary.wiley.com/doi/10.1111/j.1524-4733.2010.00722_1.x/pdf.
211. Sail K, Franzini L, Du XL, Lairson D. Clinical and economic outcomes associated with adjuvant chemotherapy
in elderly patients with early stage operable breast cancer. Value in Health. 2010;13(7):page A262 (abstract #
PCN60). http://download.journals.elsevierhealth.com/pdfs/journals/1098-3015/PIIS1098301511719556.pdf.
212. Panchal J, Lairson D, Chan W, Du XL. Geographic variation and socio-demographic disparity in the utilization
of oxaliplatin-containing chemotherapy in patients with stage-iii colon cancer. Value in Health. 2012;15(4):page
A233 (abstract # PCN138). http://download.journals.elsevierhealth.com/pdfs/journals/10983015/PIIS1098301512013204.pdf.
213. Parikh RC, Lairson DR, Cormier JN, Du XL. Cost-Utility Analysis of Various Chemotherapy Regimens among
Elderly Ovarian Cancer Patients: A Longitudinal Cohort Study. Pharmacoepidemiology and Drug Safety. 2013;
22: (Suppl. 1), page 172 (abstract #356). http://onlinelibrary.wiley.com/doi/10.1002/pds.3512/pdf.
214. Poonawalla IB, Lairson DR, Du XL. Cost assessment of advanced ovarian cancer treatment in a large cohort of
elderly patients. Value in Health. 2014;17(3):A80 (Abstract# PCN72).
http://www.ispor.org/publications/value/VIH_17-3_final.pdf.
215. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy Regimens in
Elderly Patients with Stage III Colon Cancer. Presented at the International Health Economics Association
Conference, July 13-16, 2014, Dublin, Ireland. https://ihea2014.abstractsubmit.org/presentations/11767/.
216. Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Utility Analysis of Chemotherapy and Targeted
Therapy for Advanced Non-Small Cell Lung Cancer in a Large Retrospective Cohort of Elderly Patients.
Presented at the International Health Economics Association (iHEA) Conference, July 12-15, 2015, Milan, Italy.
https://ihea2015.abstractsubmit.org/presentations/13118/.
217. Rajan S, Du XL, Lyman G. Cost Effectiveness of Pegfilgrastim versus Filgrastim in Elderly Breast Cancer
Patients Receiving Chemotherapy. Presented at the International Health Economics Association (iHEA)
Conference, July 12-15, 2015, Milan, Italy. https://ihea2015.abstractsubmit.org/presentations/13343/.
218. Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and
Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Innovations in Cancer Prevention and
Research Conference of the CPRIT, Nov. 9-10, 2015, Austin, Texas: https://s3.amazonaws.com/cpritassets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #219, page 128.
219. Liu Z, Zhang Y, Franzini L, Cormier JN, Chan W, Xu H, Du XL. Trends and Variations in Breast and
Colorectal Cancer Incidence from 1995 to 2011: A Comparative Study between Texas and SEER. Innovations in
Cancer Prevention and Research Conference of the CPRIT, Nov. 9-10, 2015, Austin, Texas:
https://s3.amazonaws.com/cprit-assets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #232, page 134.
220. Zhao H, Ding M, Niu J, Ho V, Zhang N, Du XL, Giordano S. Elderly Texas patients’ adherence to treatment
guidelines for regional colorectal cancer. Innovations in Cancer Prevention and Research Conference of the
CPRIT, Nov. 9-10, 2015, Austin, Texas: https://s3.amazonaws.com/cpritassets/cprit2015/confsite/cprit2015conf_web_v1.pdf, abstract #384, page 197.
IV. Technical Reports:
221. Du XL. Epidemiology of ageing. Proceedings of Geriatrics of Anhui Gerontology Association. 1986;10-3.
222. Du XL. A cross-sectional study of activities of daily living and active life expectancy in the elderly in two
Counties of Anhui Province. MS Degree Thesis. Anhui, China: Anhui Medical School, 1987.
223. Du XL, Goodfellow J, Broughton D, Cleary R, James OFW, Parker SG. Routine outcomes
measurement in elderly patients in a geriatric day hospital. Newcastle: University of Newcastle
and CASPE Research, 1992.
Page 33 of 39
C.V. for Xianglin Du, Ph.D.
224. Du XL. A community-based stroke register and case-control study of stroke and the quality of hypertension
control in northwest England. PhD Degree Dissertation. Manchester, England: University of Manchester, 1997.
V. Research presentation awards for projects involving students whom I advised:
1. Holmes L (DrPH student), Chan W, Jiang Z, Du XL. Influence of Androgen Deprivation Therapy on Racial
Disparities in Survival of Older Men Treated for Locoregional Prostate Cancer. Presented at the 8th Annual Health
Services and Outcomes Research Conference in Houston on November 6, 2007, and won the 1st place award in the
Equity research poster session.
2. White A (PhD student), Liu CC, Xia R, Burau KD, Cormier JN, Chan W, Du XL. Racial Disparities and Treatment
Trends in a Large Cohort of African Americans & Caucasians with Colorectal Cancer, 1991-2002. Presented at the 9th
Annual Health Services and Outcomes Research Conference in Houston on December 3, 2008, and won the 1st place
award in the Equity research poster session.
3. Nurgalieva Z (PhD student), Xia R, Liu CC, Burau KD, Hardy D, Du XL. Chemotherapy-induced Peripheral
Neuropathy in Elderly Patients with Breast, Ovarian or Lung Cancer: Findings from Large Nationwide and Populationbased Cohorts. Presented at the 9th Annual Health Services and Outcomes Research Conference in Houston on December
3, 2008, and won the 1st place award in the Patient Safety research poster session.
4. Sail K (PhD student), Franzini L, Du XL, Lairson DR. Racial Disparities Associated with Treatment and Survival in
Early Stage Operable Breast Cancer Patients. Presented at the 9th Annual Health Services and Outcomes Research
Conference in Houston on December 2, 2009, and won the 2nd place award in the Equity research poster session.
5. Nurgalieva Z (PhD student), Franzini L, Morgan R, Vernon SW, Du XL. Timely Initiation and Completion of
Chemotherapy, Ethnicity And Survival In Breast Cancer Patients. Presented at the 13th Annual Health Services &
Outcomes Research Conference: Improving the Quality of Healthcare Through Accountable Care Organizations and
Technology, on December 13, 2012 in Houston, TX, and won the 1st place award in the 'Timeliness of Care' research
poster session.
VI. Media Reports on Research Findings:
1. In May 2001, the official journal of the American Cancer Society Cancer issued a press release for our article (Du XL,
Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996. Cancer. May 1,
2001;92(4):730-737). The national news magazine Hem/Onc today published a long story entitled “Chemotherapy use
increases in elderly patients” in November 2001 Issue. It was also reported in Internal Medicine News magazine etc.
2. In September 2002, the U.S. Department of Defense Era of Hope National Breast Cancer Program meeting issued a
press release for my research project funded by this program, entitled “Axillary dissection and survival of women after
breast-conserving surgery for early-stage breast cancer”. Several radio news stations and medical news magazines,
including Ivanhoe Broadcast News, Inc., and International Medical News, reported the findings. It was also highlighted
in the UTMB Newsletter Impact on December 16, 2002.
3. In January 2003, the American College of Physicians and Annals of Internal Medicine issued a press release regarding
our article that was published in Annals of Internal Medicine, January 21st issue, 2003 (Du XL, Key CR, Osborne C,
Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant
chemotherapy in women with breast cancer. Ann Intern Med. 2003;138:90-97). The UTMB Public Affairs Office also
issued a longer press release regarding this article. The NBC and ABC news, CNN headline news, the New York Times
(January 28, 2003), and TIME Magazine (February 3, 2003) reported the findings.
Page 34 of 39
C.V. for Xianglin Du, Ph.D.
4. An internationally renowned oncology researcher, Dr. L. Balducci, was invited by the Journal editors for writing an
editorial specifically on our research article published in the September issue of 2005 in the Journal of Gerontology
(Medical Sciences), an official journal of the Gerontologic Society of America. This editorial praised the important
contributions of our research. In his editorial, Dr. Balducci wrote “Du and colleagues have provided an important
contribution to the field by: (a) demonstrating that adjuvant chemotherapy does not have a substantial impact in breast
cancer-related mortality for women aged 70 and older; and (b) providing a demonstration of a very creative use of the
SEER-Medicare database.”
5. In February 2006, the official journal of the American Cancer Society Cancer issued a press release for our article (Du
XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial Disparity and
Socioeconomic Status in Association with Survival in Older Men with Local/Regional Stage Prostate Carcinoma:
Findings From a Large Community-Based Cohort. Cancer. Published Online: February 13, 2006. Print Issue Date: March
15, 2006). The widely used wire service HEALTHDAY today and Prostate Cancer Foundation reported the findings
entitled “Poverty Behind Poor Prostate Cancer Outcomes in Black Men” By Meryl Hyman Harris on February 13, 2006.
The findings were also reported in WebMD (2/13/06), medpageTODAY (2/13/06), Urology Times (2/16/06), Patient
Health International (2/20/06), Physician’s Weekly (June 5, 2006), and many other medical professional/foundation
websites.
6. The abstract entitled “Racial Disparities and Socioeconomic Status in Association with Survival in Older Men with
Local/Regional Stage Prostate Cancer” by Du and colleagues at the UT School of Public Health has been selected for the
best abstracts award (out of 1,646 abstract submissions) at the Annual Conference of the national AcademyHealth on
June 25-27, 2006, in Seattle, WA. AcademyHealth is a leading international professional society for advancing research,
policy and practice, and a premier forum for health services research and for Agency for Healthcare Research and Quality
(AHRQ). The detail is available at http://www.academyhealth.org/arm/awards/abstracts.htm. The authors were invited to
present the paper at a special session together with the article of the year.
7. On April 23, 2007, the official journal of the American Cancer Society Cancer issued a press release for our article
(Du XL, Meyer TE, Franzini L. Meta-Analysis of Racial Disparities in Survival in Association with Socioeconomic
Status among Men and Women with Colon Cancer. Cancer. 2007 June 1;109:2161-70). The findings were also reported
in ScienceDaily.com (4/23/07), ASPH (Association of Schools of Public Health) Friday Letter (4/27/07), WebMD, ACS
(American Cancer Society) website, MedicalNewsToday, Science Daily (4/23/07), Scientific American.com (4/24/07),
and Distinctions of the UTHSC-H (July 2007).
8. In October, 2007, our article (Rohatgi N (MS student in epi), Du XL, Coker AL, Moye L, Wang M, Fang S.
Chemotherapy and Survival for Patients with Multiple Myeloma: Findings from a Large Nationwide and PopulationBased Cohort. American Journal of Clinical Oncology. 2007 Oct;30(5):540-548.) was selected by the Nature: Clinical
Practice Oncology for Research Highlights (January 2008 issue), and by the Lancet Oncology for news item.
9. In January 2007, our article “Racial Disparities and Trends in Radiation Therapy After Breast-Conserving Surgery for
Early-Stage Breast Cancer in Women, 1992 to 2002” in Ethnicity & Diseases was selected as a featured article in the
journal and its abstract was selected to be published in New England Journal of Medicine (in the issue of 2007).
10. On July 9, 2008, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Incidence Trends of Mantle Cell Lymphoma in the United States Between 1992 and 2004” (Published Online:
July 9, 2008. Print Issue Date: August 15, 2008). The findings were also reported in HealthDay website
(http://www.healthday.com/Article.asp?AID=617214) on July 18, 2008.
11. The August 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Poorer treatment and lower socioeconomic status may underlie ethnic disparities
in breast cancer survival”, that reported the findings of our study (Du XL, Fang S, Meyer TE. Impact of Treatment and
Socioeconomic Status on Racial Disparities in Survival among Older Women with Breast Cancer. Am J Clin Oncol.
April 2008;31:125-132). See weblink: http://ahrq.hhs.gov/research/aug08/0808RA3.htm.
Page 35 of 39
C.V. for Xianglin Du, Ph.D.
12. The November 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Less receipt of effective treatment by elderly black women with ovarian cancer
may underlie their poorer survival”, that reported the findings of our study (Du XL, et al. Ethnic Differences in
Socioeconomic Status, Diagnosis, Treatment and Survival Among Older Women with Epithelial Ovarian Cancer.
International Journal of Gynecological Cancer. 2008;18:660-669). See weblink:
http://www.ahrq.gov/research/nov08/1108RA7.htm.
13. The November 2008 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Prostate removal is better than radiation or watchful waiting for elderly men with
local/regional prostate cancer”, that reported the findings of our study (Liu L, et al. Long-Term Survival after Radical
Prostatectomy Compared to Other Treatments in Older Men with Local or Regional Prostate Cancer. Journal of Surgical
Oncology. 2008;97:583-591). See weblink: http://www.ahrq.gov/research/nov08/1108RA15.htm.
14. On October 20, 2008, the official journal of the American Cancer Society Cancer issued a press release for our article
(Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic Variations in Diagnosis, Treatment, Socioeconomic Status and
Survival in Elderly Patients with Non-Hodgkin’s Lymphoma. Cancer. Online published October 20, 2008, print issue
December 1, 2008). The findings were reported in websites:
Medscape Today (10/23/08), Reuters (10/21/08), American Cancer Society (10/20/08), Scientific American (10/21/08),
Science Daily (10/27/08), HealthDay (10/20/08), Medical Breakthroughs (10/21/08), ASCO (10/21/08), UTHSC-H
(10/20/08), and in numerous television websites (10/21/08) (http://us.cisionpoint.com/ListPage.aspx?id=64306815).
15. The February 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Older white men are most likely to be diagnosed with mantle cell lymphoma”,
which reported the findings of our study (Incidence trends of mantle cell lymphoma in the United States between 1992
and 2004. Zhou Y, et al, Cancer. 2008, August 15; 13(4):791-798). See weblink:
http://www.ahrq.gov/research/feb09/0209RA16.htm.
16. On April 13, 2009, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Racial Disparities and Treatment Trends in a Large Cohort of Elderly Black and White Patients with Non-Small
Cell Lung Cancer” (Published Online: April 13, 2009. Print Issue Date: May 15, 2009). The findings were also reported
in HealthDay website (4/13/09), UTHSC-H (4/13/09) and about 50 media outlets across the country. This study was also
reported in the October 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and
Quality (AHRQ).
17. On April 27, 2009, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Review of Major Adverse Effects of Androgen Deprivation Therapy in Men with Prostate Cancer” (Published
Online:, 2009. Print Issue Date: June 1, 2009). The findings were also reported in websites such as ScienceDaily
(4/27/2009).
18. The July 2009 issue of the newsletter ‘Research Activities’ of the Agency for Healthcare Research and Quality
(AHRQ) published an article entitled “Studies explore survival and treatment disparities among black and white elderly
patients with cancer”, which reported the findings of our two studies (Ethnic variation in diagnosis, treatment,
socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma."
(Cancer. 2008;113:3231-41) and Racial disparities and treatment trends in a large cohort of elderly African Americans
and Caucasians with colorectal cancer, 1991 to 2002." (Cancer. 2008;113:3400-9). See Link:
http://www.ahrq.gov/research/jul09/0709RA7.htm.
19. On August 17, 2009, our article “Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Chan W, Hardy D, Burau KD. Cardiac
Toxicity Associated with Anthracycline-Containing Chemotherapy in Older Women with Breast Cancer. Cancer. 2009
Aug 11; [Epub ahead of print]” was featured on our MDLinx.com site today. See Link:
http://www.mdlinx.com/hemeonclinx/news-article.cfm/2840535.
Page 36 of 39
C.V. for Xianglin Du, Ph.D.
20. The October 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks are
less likely than whites to receive lung cancer treatments”, which reported the findings of our study (Hardy D, Liu CC,
Xia R, Cormier JN, Chan W, White A, Burau KD, Du XL. Racial Disparities and Treatment Trends in a Large Cohort of
Elderly Black and White Patients with Non-Small Cell Lung Cancer. Cancer. 2009;115:2199-2211). See Link:
http://www.ahrq.gov/research/oct09/1009RA17.htm.
21. The November 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Older
black women with breast cancer do not receive beneficial chemotherapy as often as white women”, which reported the
findings of our study (Bhargava A, Du XL. Racial and Socioeconomic Disparities in Adjuvant Chemotherapy for NodePositive Operable Breast Cancer in Older Women. Cancer. 2009 July 1;115:2999-3008). See Link:
http://www.ahrq.gov/research/nov09/1109RA2.htm.
22. The December 2009 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Men
with prostate cancer who receive androgen deprivation therapy are at elevated risk of bone fractures, cardiovascular
mortality, and diabetes”, which reported the findings of our study on “Review of major adverse effects of androgendeprivation therapy in men with prostate cancer” (Cancer. 2009;115:2388-2399). See weblink:
http://origin.www.ahrq.gov/research/dec09/1209RA16.htm.
23. The April 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled
“Chemotherapy that contains anthracyclines is associated with later cardiac illness in breast cancer patients”, which
reported the findings of our study on “Cardiac toxicity associated with anthracycline-containing chemotherapy in older
women with breast cancer” (Cancer. 2009;115:5296-5308.). See weblink:
http://www.ahrq.gov/research/apr10/0410RA8.htm.
24. The June 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Nonplatinum
chemotherapy agents more likely to lead to hospitalizations for older women with ovarian cancer”, which reported the
findings of our study on “Risk of hospitalizations associated with adverse effects of chemotherapy in a large communitybased cohort of elderly women with ovarian cancer” (International Journal of Gynecological Cancer. 2009;19:13141321). See weblink: http://www.ahrq.gov/research/jun10/0610RA5.htm.
25. On July 12, 2010, the official journal of the American Cancer Society Cancer issued a press release for our article
entitled “Disparities in Colorectal Cancer Survival: To What Extent Are Racial Disparities Explained by Differences in
Treatment, Tumor or Hospital Characteristics?” (Published Online: July 12, 2010. Print Issue Date: August 15, 2010).
The findings were also reported in UTHSC-H (UTHealth) website (7/12/10), NewsWise
(http://www.newswise.com/)(7/12/10), USNEWs-HealthDay (7/16/10), and ASPH Friday Letter (7/23/10).
26. The September 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks
with lung cancer have higher mortality rates than whites”, which reported the findings of our study on “Racial disparities
and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients” (Cancer. 2009;115: 48074818). See weblink: http://www.ahrq.gov/research/sep10/0910RA6.htm.
27. The September 2010 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Benefits
of chemotherapy for elderly patients with lung cancer must be weighed against risk of long-term toxicities”, which
reported the findings of our study on “Chemotherapy-associated toxicity in a large cohort of elderly patients with nonsmall cell lung cancer” (Journal of Thoracic Oncology. 2010;5:90-98). See weblink:
http://www.ahrq.gov/research/sep10/0910RA29.htm.
28. The February 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Poorer
patients less likely to receive specific treatment for head and neck cancer”, which reported the findings of our study on
“Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005”
(Cancer. 2010;116:3505-12). See weblink: http://www.ahrq.gov/research/feb11/0211RA25.htm.
Page 37 of 39
C.V. for Xianglin Du, Ph.D.
29. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Colonystimulating factor is effective in reducing infection for elderly patients with non-Hodgkin's lymphoma on chemotherapy”,
which reported the findings of our study on “Comparative Effectiveness of White Blood Cell Growth Factors on
Neutropenia, Infection, and Survival in Older People with Non-Hodgkin's Lymphoma Treated with Chemotherapy” (J Am
Geriatr Soc. 2010;58(10):1885-95). See weblink: http://www.ahrq.gov/research/mar11/0311RA11.htm.
30. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Blacks have
worse colorectal cancer survival rates than whites”, which reported the findings of our study on “Disparities in Colorectal
Cancer Survival: To What Extent Are Racial Disparities Explained by Differences in Treatment, Tumor or Hospital
Characteristics?” (Cancer. 2010;116(19):4622-31). See weblink: http://www.ahrq.gov/research/mar11/0311RA19.htm.
31. The March 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Medicareinsured patients with head or neck cancer differ little in mortality risk because of race or ethnicity”, which reported the
findings of our study on “Racial/Ethnic Disparities in Socioeconomic Status, Diagnosis, Treatment and Survival among
Medicare-insured Men and Women with Head and Neck Cancer” (J Health Care Poor Underserved. 2010;21(3):913930). See weblink: http://www.ahrq.gov/research/mar11/0311RA20.htm.
32. On May 5, 2011, American Association for Cancer Research (AACR) issued a press release for our article (White A,
Vernon SW, Franzini L, Du XL. Racial and Ethnic Disparities in Colorectal Cancer Screening Persisted Despite
Expansion of Medicare's Screening Reimbursement. Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):811-7):
http://www.aacr.org/home/public--media/aacr-in-the-news.aspx?d=2366. The findings were also reported in UTHealth,
HealthDay News, ScienceDaily, MedicalNews, MDNews, and HealthWorldWeb.
33. The June 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Chemotherapy
and radiation therapy for lung cancer linked to cardiac disorders”, which reported the findings of our study published in
Annals of Oncology. 2010 Sep;21(9):1825-33. See weblink: http://www.ahrq.gov/research/jun11/0611RA17.htm.
34. The September 2011 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled
“Minority patients with nonsmall-cell lung cancer are less likely to receive hospice services than whites”, which reported
the findings of our study published in Cancer. 2011;117 (7):1506-1515. See weblink:
http://www.ahrq.gov/research/sep11/0911RA13.htm.
35. Our research article “Racial disparities in the use of hospice services according to geographic residence and
socioeconomic status in an elderly cohort with nonsmall cell lung cancer” has been named as one of the top clinical
cancer research advances of the year and featured in 2011 Clinical Cancer Advances: ASCO’s Annual Report on
Progress Against Cancer (pages 30-32), which was published online on December 5, 2011 in the Journal of Clinical
Oncology and is available from www.Cancer.Net.
36. The September 2012 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Several
factors influence completion of chemotherapy in elderly patients with stage-III colon cancer”, which reported the findings
of our study published in Medical Oncology. 2011;28:1062-74. See weblink:
http://www.ahrq.gov/research/sep12/0912RA12.htm.
37. The November 2012 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled
“Radiation therapy linked to dry mouth in elderly patients with head and neck cancers”, which reported the findings of
our study published in American Journal of Therapeutics. 2011;18: 206-215. See weblink:
http://www.ahrq.gov/research/nov12/1112RA10.htm.
38. The UTSPH (1/23/2013), ASPH Friday Letter (1/26/2013), and News on the Go (1/29/2013) reported our recent
research findings funded by the AHRQ: “UTSPH researchers compare the effectiveness of chemotherapy options for
ovarian cancer”. See weblink: https://sph.uth.edu/2013/01/utsph-researchers-compare-the-effectiveness-of-chemotherapyPage 38 of 39
C.V. for Xianglin Du, Ph.D.
options-for-ovarian-cancer/, http://fridayletter.asph.org/press.cfm?FL_Index=1762, and
https://inside.uthouston.edu/notg/index.htm.
39. The January 2013 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Elderly
colon cancer patients receiving chemotherapy after surgery are at risk for various toxicities”, which reported the findings
of our study published in American Journal of Clinical Oncology. 2012;35:228-236. See weblink:
http://www.ahrq.gov/legacy/research/jan13/0113RA17.htm.
40. The June 2013 issue of the newsletter ‘Research Activities’ of the AHRQ published an article entitled “Combination
chemotherapy increases the risk for adverse events in elderly patients with colorectal cancer”, which reported the findings
of our study published in Annals of Oncology. 2012;23:1053-11. See weblink:
http://www.ahrq.gov/news/newsletters/research-activities/13jun/0613RA40.html.
41. The ‘MedicalResearch.Com’ reported (11/13/2014) our recent research findings funded by the AHRQ and CPRIT:
“Colon Cancer: Improved Screening and Chemotherapy Contribute To Improved Survival”. See weblink:
http://medicalresearch.com/cancer-_-oncology/coloncancer/colon_cancer_improved_screening_and_chemotherapy_contribute_to_improved_survival/8950/#more-8950.
42. On August 11, 2015, UTHealth issued a press release (https://www.uth.edu/media/story.htm?id=fcfafe64-039f-4de7baaa-4e0e93858256) for our research article (Du XL, et al. Comparative Effectiveness of Chemotherapy Regimens in
Prolonging Survival for Two Large Population-based Cohorts of Elderly Adults with Breast and Colon Cancer in 19922009. J Am Geriatrics Society. 2015 July 22). The findings were reported in 35 news outlets, including
HealthinAging.org, Science Daily, MedicalXPress.com, NursingTime.Net, ScienceNewsLine, TheStatesman,
ETHealthWorld.com, AJMC-ManagedMarketsNetwork, News-Medical.net, Yahoo News, Dallas Sun,
MedicalNewsToday.com, thenewsworthly.com, inquisitr.com, breastcancer.org, and ASPPH Newsletters.
Page 39 of 39